ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000333.1|Cyclomarin_1 # 1 # 1134 # -1 # ID=1_1;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.724	BGC0000333.1|Cyclomarin_1 	1	1134	-	Loose	1500	166.007	rphB	36.76	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	TTGCTGATCGACCTGGCCGACGCCGAAGCCGCGACGTCCGGAGGCAAGGCGGCAGTGCTCGCCCGGCTCCTCGAAGCAGGTCTGCCGGTCCCGCCTGGTTTTGTGGTGCCGGCCTCCGCCTACGAACAGGCAGCCGACGGCCCCTCCGCCGAGCTCGCCGCCGCGATCGCCCAGGCGCTGCCGCGGCTCGGCGACGGTCATGTCGCCGTACGCTCCTCGGCGACCAACGAGGACACCGCCCAGGCCACCGCCGCAGGGCAGCACGACACCTTCCTCGGCGTCCGCGGGCCCGACGAGGTGGTCGACGCCGTGAGCAGATGTTGGGCCTCGCTGTGGTCCGAGCGCGCCGTGGAATACCGGCGCCGGCGGGGAGACACGGAGTCACCGACGATCGCCGTCCTGGTGCAGCGTCTAGTGGACGCGGACGTCGCTGGGGTGATGTTCACCGGCGATGACATCCGGCTGGAGGCGTCCTGGGGGTTGGGCGAGAGCGTCGTCAGCGGCCACGTAACACCGGACTCCTGGATGGTGTCCGGCGGCGACATCACCCATCGGGCGCTCGGCACGAAGAAGACCCGGATCGACCGCACGATCTGCCGCGAGGTGGAACCGGCCGACCGGGATCGCTTCTGCCTCACCGACGACGAGGTCACCCGGCTCGCACAGCTCGGTCGGCAGATAGCCGCTCTGCTGGGCGGCCCACAGGACATCGAGTGGGCAATCGCCGATTCCCGGATCTGGATACTTCAGTCCCGCCCGGTGACCACCGCCCTCCCCGCCACACCCCCGGCCGCCGCGGCCGCCGAGGGCAAGGCCCTCACCGGTACGCCCGGAAGCCCGGGCATCGCCACCGGACCGGCGCGCGTGGTGCGCGGCCCCGCCGACTTCGCCCGAGTCCGGCCCGGTGACGTACTCGTCTGCCGCACCACGGATCCGTCGTGGACCCCGCTGTTCGGCGTGGTCGCCGCCGTCGTCACCGAAGTCGGCGGCCTGCTCTCGCACGCCGCGATCGTCGCCCGCGAGCAGGGCGTCCCTGCCGTCCTGGCCGTCCCGGACGCGACGACAGCCCTGCCCGACGGCGCGCCGGTGGAGGTGGACGGAAACTCCGGCTCGGTGGCACGCCGTGGTTCCTAA	MLIDLADAEAATSGGKAAVLARLLEAGLPVPPGFVVPASAYEQAADGPSAELAAAIAQALPRLGDGHVAVRSSATNEDTAQATAAGQHDTFLGVRGPDEVVDAVSRCWASLWSERAVEYRRRRGDTESPTIAVLVQRLVDADVAGVMFTGDDIRLEASWGLGESVVSGHVTPDSWMVSGGDITHRALGTKKTRIDRTICREVEPADRDRFCLTDDEVTRLAQLGRQIAALLGGPQDIEWAIADSRIWILQSRPVTTALPATPPAAAAAEGKALTGTPGSPGIATGPARVVRGPADFARVRPGDVLVCRTTDPSWTPLFGVVAAVVTEVGGLLSHAAIVAREQGVPAVLAVPDATTALPDGAPVEVDGNSGSVARRGS	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	42.65	gnl|BL_ORD_ID|2235|hsp_num:0	2528			279	1029	rifampin; rifaximin; rifabutin; rifapentine
BGC0000333.1|Cyclomarin_2 # 1240 # 1896 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.685	BGC0000333.1|Cyclomarin_2 	1240	1896	+	Loose	1900	25.7942	MexK	32.61	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCACTGCCATGACTCATGCCTCATCGCCAGAACTGTCTGTTCTGCACGCCCTGCGGGTGACCGGGGTGGCCGGCGACGCGGCAGTCTCCCGCCGTAGCGGCATCGACCAGGACACCGCCGCCGAACTCCTGCGGGACTTCGAAGCCTACGGGTGGGTGACCCACGTCGAATTCGGGGAGACCAGCGGGTGGGCGCTCACCGAGTTCGGCCGGGACCAGGACTCCCGGAAACTGGCCGAGGAACTCGACCAGGCCGGCGGCCGCGCGACGGTCGAGCAGGCGCACAAGGAGTTCGAAGTCCTCAACGGACGGCTGGTCAAAGCCTGTACCGACTGGCAGCTGCGGCGCACCGAGGGCGACCGGCTGGCATCCAACGACCACAGCGACCCGCAGTGGGACGGCCGGGTTCTGGACGAGCTCACGGTGATCGGCGCGGAGCTGACCCGGCTGACCGACTCTCTCGTCAGCGTGCTGGCTCGCTTCGACGGCTACGCCGATCGGTTCGGCACCGCGTTGGCGCGGGCACGTGCCGGAGACGGGCAGTGGGTGGCCGGAGTCGGTGTCGCGTCGTGCCACGCCGTGTGGATGGAGCTTCACGAGGATCTGCTGTCGACACTCGGAATTCCGCGTGGCGTCGAACCGGGAAGCCGGTAA	MLTAMTHASSPELSVLHALRVTGVAGDAAVSRRSGIDQDTAAELLRDFEAYGWVTHVEFGETSGWALTEFGRDQDSRKLAEELDQAGGRATVEQAHKEFEVLNGRLVKACTDWQLRRTEGDRLASNDHSDPQWDGRVLDELTVIGAELTRLTDSLVSVLARFDGYADRFGTALARARAGDGQWVAGVGVASCHAVWMELHEDLLSTLGIPRGVEPGSR	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	21.27	gnl|BL_ORD_ID|2016|hsp_num:0	2206			477	606	erythromycin; tetracycline; triclosan
BGC0000333.1|Cyclomarin_3 # 1972 # 2508 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.715	BGC0000333.1|Cyclomarin_3 	1972	2508	+	Loose	250	24.2534	FosB2	26.79	3005100	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	GTGGGGTACCAGCAGGCCGACCTTCTCGGCCGGCGGCTCGCCCGGCTGCCGATCGACGCGGTGTGGCATTCGATGCTGCCGCGTGCCGCCGCGAGCGCGCGCGAGATCGCGAAGCACCTGCCCGACGTGCCGGTCGCCGAGGCGGCCGAACTCATCGACCACGTGCCGTACGTGCCGAACGCGGACGAGATGCCCCGCGCCTGGGCCGGCTTCTTCGACGGCTACGACGAGGCTGAGGCGGCGACCGGCCAGCGGACCGCGGAGGCCCTCGTGGCACGCTTCACCAAGGCCCCTGAGCGCAACGAGGCCGAGTCGCACGAGGTTCTGATCACGCACGCGTACCCGATCGCGTGGCTGGTGCGGCACGCGCTGGAGGCCCCGCCTACCCAGTGGCTCGGCCTGGACAGCGCGAACACGGGCCTCACCGTGATCGAGTACCGGGTCGGCCTGTCACCCACCCTGGTGATGTTCAACGACCAGAGCCACCTGTCCGGTGACCTACGCTGGACCGGATTCCGCGCGGCCGCACGTCCGTGA	MGYQQADLLGRRLARLPIDAVWHSMLPRAAASAREIAKHLPDVPVAEAAELIDHVPYVPNADEMPRAWAGFFDGYDEAEAATGQRTAEALVARFTKAPERNEAESHEVLITHAYPIAWLVRHALEAPPTQWLGLDSANTGLTVIEYRVGLSPTLVMFNDQSHLSGDLRWTGFRAAARP	MLQGINHICFSVSNLEKSIEFYQKILQAKLLVKGRKLAYFDLNGLWIALNVEEDIPRNEIKQSYTHMAFTVTNEALDHLKEVLIQNDVNILPGRERDERDQRSLYFTDPDGHKFEFHTGTLQNRLEYYKEDKKHMTFYI	128.06	gnl|BL_ORD_ID|2816|hsp_num:0	3832			78	246	fosfomycin
BGC0000333.1|Cyclomarin_4 # 2574 # 3518 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.705	BGC0000333.1|Cyclomarin_4 	2574	3518	+	Loose	600	310.071	oleC	53.57	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGACTACGCATTCCAGGCCGAGGGTCTGGTCAAACGCTTCGGCAAGAAGACCGCGCTCAGCGGACTCGACCTCGCGGCGCCGGCCGGGACGGTGCTGGGCGTGCTCGGGCCCAACGGCGCGGGCAAAACCACCGCCATCCGGATCCTGGCGACACTGATGCGGCCGGACGAGGGCCGCGCCGTCGTCGCCGGGTTCGATGTCGTGACCCACGCGTCCCAGGTGCGGCGTCTCATCGGTCTGACCGGGCAGTACGCCACCGTCGACGAGGAACTGACCGCGTTCGAGAACCTCGTGATGGTCGGGCGGTTGCTTGACCTGCGGAAAGCAGAGGCGAGGTCCCGCGCCGACGAGCTGTTGCGGCAGTTCGATCTGCTGGAGGCGGGGAAGCAGCGGGCCTCGGTGCTGTCCGGCGGCATGCGCCGTCGCCTCGACCTCGCGGTGAGCCTGGTCGGCCGGCCGCGGATCGTCTTCCTCGACGAGCCCACCACCGGGCTGGACCCGGGCCGGCGCGAAGATCTGTGGCAGCTGGTGCGAAGGATGACGGCCGAGGGGGTGACCGTGCTGCTGACCACGCAGTACCTGGAGGAAGCGGACGCGCTGGCCGACCACATCTGTGTGATCGACGAGGGCCGGGCGATCGCCGACGGGACGCCCGCCGATCTGAAACGGATCGTGGGCGGGCAGGCGATCGTCGTACGGCCGGTGGACCCGCAGCAGACGGATGTGGCCGTGGAGGTGCTGGAGCAAGTTGCCGGGCGGCGCGCCGAACCGGTCGACCGCGGCGTGGTCACCGTGCCGGTGGACGACGACCTCGTGCTGCTCGAGGTGGTGAAGCGCCTGGCCGCCGCAAAGGTGCGGCTGGCCGAGTTCTCGCTCCGCCTGCCCAGCCTGGACGAGGCCTTCTTCGCACTGACCGGCCGATCCAAGGAGGCGCGGCGATGA	MDYAFQAEGLVKRFGKKTALSGLDLAAPAGTVLGVLGPNGAGKTTAIRILATLMRPDEGRAVVAGFDVVTHASQVRRLIGLTGQYATVDEELTAFENLVMVGRLLDLRKAEARSRADELLRQFDLLEAGKQRASVLSGGMRRRLDLAVSLVGRPRIVFLDEPTTGLDPGRREDLWQLVRRMTAEGVTVLLTTQYLEEADALADHICVIDEGRAIADGTPADLKRIVGGQAIVVRPVDPQQTDVAVEVLEQVAGRRAEPVDRGVVTVPVDDDLVLLEVVKRLAAAKVRLAEFSLRLPSLDEAFFALTGRSKEARR	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	96.62	gnl|BL_ORD_ID|2050|hsp_num:0	2264			12	936	oleandomycin
BGC0000333.1|Cyclomarin_5 # 3515 # 4309 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.674	BGC0000333.1|Cyclomarin_5 	3515	4309	+	Loose	500	201.445	tetB(58)	41.13	3003981	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCACCACTGCCGAGACGTCCCGGTCGAGGCCGCTCGGGCTGGTGCGGCACAGCGCCGTCCTGGCCAAGCGAAGCCTGGTCAAGACCAAGCGCAGCCCCGGCTACCTGATCAACGGGGTGATGACCCCAGTGATCTTCTTGGTGCTGTTCCTGTACCTGTTCGGCGGGGCGGTGTCCGGGTCCACCGACAGCTACCTGCAGTACCTCTTCCCCGGCATCCTTGTGATGACCACCAGCCTCTCCGGGATGCTGGCCACGGGGCTGAACCTCAACATCGACGTCAAGAAGGGCATCTTTGATCGCTTCCGGAGCCTGCCCATCGACCGCGCGGCGCCGCTCCTCGGTTCCGTCGCCGCCGACGTCGTCCGGTACGTGGTCGCTGTGGTCATCCTGTTCGGCATCGGGTACGCGCTCGGGTTCCGGGTGCAGAGCGACCCGCTGTCGACGCTCGCCGCCGTGCTGCTGGCCGTCGCTTTCGGCTTCTGCCTCAGTTGGGTCACGGTGTTCCTCGGCGTTCTCGTCCGGGACGAGGGCGCGGTGCTCGCGTTCTCGTTCGTCGCCTTCCTGCCGCTGGTTCTCGGGACGAGCCTGTCGGCACCGGTCGACACGCTGCCGGGGTGGCTGCGAGCTTGGGCGAACGTCAACCCGGTCACGCACGCCATGGACGCCTGCCGTGCGCTGCTCAACGGCGGTGCTGCCGGCGACGCGGTCACCCAGACCTTGATCTGGTCGGCTGTCCTGCTCGTGATCTTCTGCCCGTTGGCCGTGCTCGCCTACCAGCGTCGGGAGTGA	MTTTAETSRSRPLGLVRHSAVLAKRSLVKTKRSPGYLINGVMTPVIFLVLFLYLFGGAVSGSTDSYLQYLFPGILVMTTSLSGMLATGLNLNIDVKKGIFDRFRSLPIDRAAPLLGSVAADVVRYVVAVVILFGIGYALGFRVQSDPLSTLAAVLLAVAFGFCLSWVTVFLGVLVRDEGAVLAFSFVAFLPLVLGTSLSAPVDTLPGWLRAWANVNPVTHAMDACRALLNGGAAGDAVTQTLIWSAVLLVIFCPLAVLAYQRRE	MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT	97.42	gnl|BL_ORD_ID|4708|hsp_num:0	2518			69	810	tetracycline
BGC0000333.1|Cyclomarin_6 # 4227 # 7358 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0000333.1|Cyclomarin_6 	4227	7358	-	Loose	400	31.5722	vanR gene in vanD cluster	30.16	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCACGTCGGGATGCTCGGCCCTCTGCTGGTGACCGCCGGCGGAACCGAGGTGCGGATCGGTGGTGCCCGGCTGCGCACCCTGCTGATCCGGCTGGCGCTGGAACCCGGGCGGCCCGTGCCGACCGAGTCGCTGACCCGGTCACTGTGGCCGGAGGACCGGCTCACCGACACCTCGCACGCGCTGCATGCACTCGTCTCACGGCTGCGCAGGTCACTGCCAGAGCCCGCCGTGGTGGAGGGCATCCCAGGCGGATACCGGCTGCGGCTGCCCCCGGCATCGGTCGACGTCACGCACTTCGAGCAGCTGCGACAGGAGGGTCAGCGCCGGCTCCGTGAGGGCGACCCGGCGCACGCCGGCCGGATGCTCCGGGAAGCGCTCGCCCTGTGGCGCGGCGAGCCGCTCGCCGACGTGCGGGACCTGCCGTTCGCGGCGCAGGAAGTCAACCGGCTCACCGAACTGCGGCTCACCGCGCTGGAGGACCGCGTCGCCGCCGACCTGGCGTGCGGCGCCGACGACCTGGTCGCGGAACTGCAGGGGCTGACGGCGAGCTACCCGTCCCGGGAGCGGCTGCATGCGCTGCTGGTCCGCGCCCTGCACGCGGAGGGCCGCCAGTCGGAGGCGCTGCGCACCTACGCCGGCTATCGGCGCTACCTCGCTGATCAGCTCGGCAGCGACCCTGGGCCCGAACTGCGCGCCGCTCACCTGGCGGTGCTGCGGGACGACCGCGGCACCGAGCGGTCCCGGGGCAACCTGGGTGCACCGCTGACGTCGTTCGTCGGCCGGGCCGCGGAACGCCGCCGGATCCACGAGCAGCTGCGCGAGCAGCGCCTGGTGACGCTGGTCGGCACCGGCGGCGTGGGCAAGACCCGGCTGGCGACCACGCTGGCCGCCGAACTGGCCGACCGGACCTCGGACGGCGTCTGGCTGATCTCGCTGGCCACGGCAACCGCCGCCACCGACGTGCCGCAGACGATGCTCCACACCCTGGGGGTACGTCCCGCCGACCGGTCCGCCGACCCGGTACGCGCACTGGTCGCCGCGCTGGCGCCGACCGAGACCGTGCTCATCATGGACAACTGCGAGCATGTCATCGAGGCAGCGGCCCGGGTCGTCGAGCAACTTCTGGTGGGCTGCCCGCGGCTGCGGATCGTGGCGACCAGCCGGGAACCGCTGATGATCCCGGGCGAGGCCCTGAGCCCGGTGCCGCCGCTGCCGGTGCCGCCATCGGGGACGCCGCTGCCCAAGGCGCTGGATTCTCCCGCGGTGCGGCTGCTCGTCGAGCGCGCCCGCGCGGCACACCCCGCGTTCGCCGTGACCGAGAAGAACATCGGGCACATCGTGGAGACCTGCCGCCGGCTGGACGGCCTGCCGCTGGCCATCGAGCTGGCCGCCGCCCGGCTGCGGTCCATGTCGATCGAGCACCTGGCCGCCCGCCTGGACGACCGGTTCCGTCTACTCACCGGTGGCAGCCGGACCGCGCTGTCCCGTCACCAGACCCTGCACGCCGCAGTGACCTGGAGCTGGGACCTGCTGAGCGAGCCGGAGCGGCGGGCGCTCCGCAGCGTGGCGGTCTTCTCGGGCTCGTTCGACGCCGCGGCGGCCGAGTCACTCGGAGTCGCGACGGAACTGCTCGACGCCCTCTTCGACCGGTCGCTCATCACCCTGATCGACGGCCCCGAACCCCGCTACGCCGTGCTGGAGACGATCCGGGAGTACGCCCTGCAGCACCTGACCGAAGCCGGCGAGGTGCTCCGGATGCGACACGACCACGCGGCACACTTCCTGGCGTTGGCAGAGCAGGCGGCACCACATCTGCGCGGCCCGCGACAGCACCCGTGGATGCTGCGGCTCGACGCGGAGAGCGGCAATCTGCTGGCGGCCCTGCGCTTCGCGACCGACTTCGGCGACGCGGACACCGCGGTCCGGATGGCTGCCGCCCTCTGGTACGCCTGGGTAGTCAACAGCGAGCACACCGAGGCGGTCGAGCGGCTGCGCCGAGCCCTGGCGATGCCCGGCCCGGTGCGGGCGCACGCCCGCCGTACTGCTGCGATCGGCCTGCTCTTCAGCAGCGTCCTCGGCGGCGACCGGGAGGCAATGCGGGACGCCCGGCGCCGGGTGCTCGACGACGGCACACTGCCGCCGGCGGACCCCCTGGCCACGGCGCTGCTGGCGGTGACCTCCGACGACCCCGCCCCGGTGTTCGCCGCCGACGGGCCGGAGACCGACCCGTGGGAGCGGGGTCTGCTCTGGTGGATCAGGTCGTTCCTCAGCGCGAGGCGGGGTGAAGCCGCCACGCTGTGCGACGCCCTCACCCGCGCCGAGGACGGATTCCGCCGGGCCGGGGACCGCTGGGCGCTCGCCATGTGCCTGCTGAGCACGAGCGACGCCCGGCTGACGGTCGGCGATCTGGACGCCAGCCTGCGTGCTCTGGAGGAGTCGACGGAACTGGCGCACGGCTTGGGCACTAACGACCAGCAGCGACTCTGGCTGGCGGTCGTTCGGCTGCGCAGCGCCGACGTCCGCGGGGCCCGCGCCGAGCTGCTGAGCATCGTGGAGCAGGCGTCGGCCGGCCGTTACGCGTCCACCGCCCGGATCTTCCTGGCCGACCTGTGCCGCCAGGAGGGCGACTTGGACGCCGCCGCTCGCCAGCTGGAGCACGCCGCCAACGACCGCGGGGCCCAGCAGGACCGGGTTTTCCGGTCGCTGTACCGGTTGTCGGCCGGCCACCTGGCCGTGGCCCGCGGCGACCTGCGCGGCGCGGCGCGGGACCTGCGCGAGGGTCTGGACCTGATCGCGGCGATGCCGCACGTGCCGATGGGTGCCACGGTCGGTGCCGGCGTCGCGGCCCTGCTGTTGCGTGCCGGTTCGCCGGCGTCGGCGGCCCAGGTGCTCGGCGCCGGCCGCGCACTGACCGGTGCGGCCAACGCCGACGTCCTGCGCCTCGAGGAAGAGCTCGGCGAACAGCTGGGCACGAGCGGGTATGCGGACGCCTGCCGCCTGGAACCCCCCGCCGCCCTGGCCCTCATCCAGCAGAGTCTCGCCGCCTTCACTCCCGACGCTGGTAGGCGAGCACGGCCAACGGGCAGAAGATCACGAGCAGGACAGCCGACCAGATCAAGGTCTGGGTGA	MHVGMLGPLLVTAGGTEVRIGGARLRTLLIRLALEPGRPVPTESLTRSLWPEDRLTDTSHALHALVSRLRRSLPEPAVVEGIPGGYRLRLPPASVDVTHFEQLRQEGQRRLREGDPAHAGRMLREALALWRGEPLADVRDLPFAAQEVNRLTELRLTALEDRVAADLACGADDLVAELQGLTASYPSRERLHALLVRALHAEGRQSEALRTYAGYRRYLADQLGSDPGPELRAAHLAVLRDDRGTERSRGNLGAPLTSFVGRAAERRRIHEQLREQRLVTLVGTGGVGKTRLATTLAAELADRTSDGVWLISLATATAATDVPQTMLHTLGVRPADRSADPVRALVAALAPTETVLIMDNCEHVIEAAARVVEQLLVGCPRLRIVATSREPLMIPGEALSPVPPLPVPPSGTPLPKALDSPAVRLLVERARAAHPAFAVTEKNIGHIVETCRRLDGLPLAIELAAARLRSMSIEHLAARLDDRFRLLTGGSRTALSRHQTLHAAVTWSWDLLSEPERRALRSVAVFSGSFDAAAAESLGVATELLDALFDRSLITLIDGPEPRYAVLETIREYALQHLTEAGEVLRMRHDHAAHFLALAEQAAPHLRGPRQHPWMLRLDAESGNLLAALRFATDFGDADTAVRMAAALWYAWVVNSEHTEAVERLRRALAMPGPVRAHARRTAAIGLLFSSVLGGDREAMRDARRRVLDDGTLPPADPLATALLAVTSDDPAPVFAADGPETDPWERGLLWWIRSFLSARRGEAATLCDALTRAEDGFRRAGDRWALAMCLLSTSDARLTVGDLDASLRALEESTELAHGLGTNDQQRLWLAVVRLRSADVRGARAELLSIVEQASAGRYASTARIFLADLCRQEGDLDAAARQLEHAANDRGAQQDRVFRSLYRLSAGHLAVARGDLRGAARDLREGLDLIAAMPHVPMGATVGAGVAALLLRAGSPASAAQVLGAGRALTGAANADVLRLEEELGEQLGTSGYADACRLEPPAALALIQQSLAAFTPDAGRRARPTGRRSRAGQPTRSRSG	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	449.57	gnl|BL_ORD_ID|1052|hsp_num:0	1004			459	642	vancomycin; teicoplanin
BGC0000333.1|Cyclomarin_7 # 7528 # 8742 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.682	BGC0000333.1|Cyclomarin_7 	7528	8742	+	Loose	880	26.1794	arlS	57.14	3000839	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCTCATGGCGAGCCTACCCTCACGTTGTACGCCAACGAACTCTGCGATCCGGAGCTGTACCGGCAAGGAAATCCGGAAGACCTGTGGCGGCGGATGCACGCGGCGGCGCCCGTTCACGAGGGCGCTTTCGAGGGCCGGCGGTTCCACGCCGTCATCTCGCACGCGCTGATCTCGCGGATGCTGAAGGACCCGAAGGGGTTCTCCTCCGAGCGGGGGATGCGGCTCGACCAGAACCCGGCCGCCACCTCGCTCGCGGCCGGCAAGATGCTGATCATCACAGACCCGCCGCGGCACGGCAAGATCCGGCGCATCGTCAACTCGGTCTTCACACCGCGCATGGTGGCCCGCCTCGAAGAGAACATGCGGGTCACAGCCGCCGGCATCGTTGACCAGGCGATCGAGGAAGGCGAGTGCGACTTCACCGACGTGGCCGCGCGGCTGCCGCTCTCGGCCATCTGCGACATGCTCGGTGTGCCGCCGGAGGACTGGGACTTCATGCTGGACCGGACCATGGTGGCGTTCGGGTCGGGCGAGGCCGACGAGCTCGCGATGGCCGAGGCGCACGCCGACATCCTGTCGTACTACGAGGACTTGATCCGCCGTCGTCGGCGCGAACCACGCGAGGACGTGGTGACCGCGCTGGTCAACGGCGTCGTCGACGGCACCAAGCTGACCGATGAGGAGATCTTCCTCAACTGCGACGGCCTGATCTCCGGCGGCAACGAGACGACTCGGCACGCCACGATCGGCGGGTTCCTGGCGCTGCTCGACAACCCGGAACAGTGGGAGACGTTGCGCGACGATCCCGGGCTATTGCCAGGCGCGGTGCAGGAGATCCTCCGATACACCAGCCCGGCGATGCACGTTCTGCGGACCGCGGTCGCGCCGACCCGGATCGGGGAGTACGCGCTGAACCCGGGGGATCCGGTCGCACTGTGGCTGTCGGCCGGCAACCGCGACCCCCAGGTGTTCGCCGATCCCGATCGCTTCGACATCACCCGGAGCCCCAACCCGCACCTCACCTTCTCGACCGGCGCGCACTACTGCCTCGGGTCCGCACTGGCCACGTCGGAGCTCACGGTGCTCTTCGACCGGCTGCTGCGGCGGGTGGACAGCGCCGAACTCACCGGGCCACCCCGGCGTACGCGATCGATCCTGATCTGGGGTTACGACTCGGTACCCGTGCGGCTGACGGCCGGATCGGAGCGATGA	MPHGEPTLTLYANELCDPELYRQGNPEDLWRRMHAAAPVHEGAFEGRRFHAVISHALISRMLKDPKGFSSERGMRLDQNPAATSLAAGKMLIITDPPRHGKIRRIVNSVFTPRMVARLEENMRVTAAGIVDQAIEEGECDFTDVAARLPLSAICDMLGVPPEDWDFMLDRTMVAFGSGEADELAMAEAHADILSYYEDLIRRRRREPREDVVTALVNGVVDGTKLTDEEIFLNCDGLISGGNETTRHATIGGFLALLDNPEQWETLRDDPGLLPGAVQEILRYTSPAMHVLRTAVAPTRIGEYALNPGDPVALWLSAGNRDPQVFADPDRFDITRSPNPHLTFSTGAHYCLGSALATSELTVLFDRLLRRVDSAELTGPPRRTRSILIWGYDSVPVRLTAGSER	MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF	89.58	gnl|BL_ORD_ID|165|hsp_num:0	182			1164	1206	ciprofloxacin; acriflavine; norfloxacin
BGC0000333.1|Cyclomarin_8 # 8745 # 9530 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.711	BGC0000333.1|Cyclomarin_8 	8745	9530	+	Loose	400	30.4166	ErmS	36.23	3001304	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCGGCTCGCGCACCATCGTTCCCCGTCGACTGCGGCTGCCCGACGGTCGTCAGGTGTGGTGCACCCGCCCGGCCGAGGCCCTGCTGATGTGGCGTGAGATCAGCAGCGACGGCTTCTACCGGCGTGGCGTGCGGCAGCTGCGGCCGGGCGGCGTGGTGCTCGACATCGGCGCCAACGTCGGGCTGGTGTCAGTCGCCCTCGCCGCCGAGAACCCGGGCGTACGGATCATCGCGGCCGAACCGGTGCCCGACACGTTCGAGTGCCTGCGGGCCAATTTCGAGCAGCACGTCCCCGGCGGTGTGGCGGTGCGTACCGCGGTCGCCGCCACCGCCGGCACGCAGCAGCTGACCTACTACCCGGACGCGCCCGGCAACTCCGGGCTGTATGCGGACCGGCAGGCGGACGACGCCCTCACCCGGACCTTCATGCGCAACGGCGGTATGGACGATGAGGAGATCGACCTGCTCATCGAGGGCCTGCACGAGGGCCGGACCATCGAGGTCCCGGTCACAACGGTCTCCGGCCTGCTCCGCCAGCACGGCGTCGAGCGGGTCGCGCTGCTGAAGGTCGACGTGGAGCGGGCCGAACTGGACGTCCTGCGCGGCGTCGAAGCGGCCGACTGGGCCCGGATCGGCGCGGTCGTCGCCGAGGTGCACGACGAACAGGGACGCCTCACCGAGTTCTGCGGCCTGCTGCACGCGGCGGGCTTGTCGACGGAGACCCGGCAGGATCCGAGCCTGGACGGAACGGAGCTCTTCGAAGTGTACGGAGACCGGTCGTGA	MTGSRTIVPRRLRLPDGRQVWCTRPAEALLMWREISSDGFYRRGVRQLRPGGVVLDIGANVGLVSVALAAENPGVRIIAAEPVPDTFECLRANFEQHVPGGVAVRTAVAATAGTQQLTYYPDAPGNSGLYADRQADDALTRTFMRNGGMDDEEIDLLIEGLHEGRTIEVPVTTVSGLLRQHGVERVALLKVDVERAELDVLRGVEAADWARIGAVVAEVHDEQGRLTEFCGLLHAAGLSTETRQDPSLDGTELFEVYGDRS	MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR	81.82	gnl|BL_ORD_ID|671|hsp_num:0	727			180	381	lincomycin; tylosin; pristinamycin IC; carbomycin; niddamycin
BGC0000333.1|Cyclomarin_9 # 9527 # 10255 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.738	BGC0000333.1|Cyclomarin_9 	9527	10255	+	Loose	1450	27.7202	BahA	42.86	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	GTGACGGCGACCCTGGTAACCCTCGGGGGCAGCCCGGCGGCCCGCACACTGGTCTGCGTGCCGCACGCCGGTGGCAGCGTGGTGGCGTTCCGGGGATGGGTCCGGGCCACCGCGGCGGAGGGCCTGGCCGTCCGGGCGGTGCACTGGGAGGACGAAGCCGGCCGGTCCAGCATCGAGCATCGGGCCGACGCGCTCGCCGCCGAGGTACGGGACCTCCCGGAACCCTGGATGCTGCTGGGACACAGCCTCGGGGCCCTGATCGCTGCGGAGACCGCGCGGCGGATCACCGGCCCGGCCCCGGAGCTGGTCGTGCTCTGCGCCGCGGCGCCGCCCGGCTACCCGCGCGGGTTCCCGCCCCGCGTGCTCACCGCCTCCGACGCGGGGATGGCGGAGTACGTACGTCGGCTCGGCGGCACGCCGGAGGAGATCCTCACCCACCCGGAGTTTGGGCCGCAGCTGCTCGCCCAGCTCCGCATCGACCTGGACCTCATCGAGCGCTACGAACCCACCTACGACCGGCCGCTGTCGTCGCCGGTATCGGTCTACGGCGGCGCGTCGGACGCCTCGGTGCCGGTCGAGGTGCTGGCCGGCTGGCGGGAGTTCGCCCCGCAGGCCACGATGCGAGTCTTCGCCGGCAACCACTTCTTTTTGCACGACAGTCCGGCCGAGGTATGCCGGGAGTTGGTCGCCGACTATGCCCGGACCACTGCGGACCGTCTCGGCGGGTAG	MTATLVTLGGSPAARTLVCVPHAGGSVVAFRGWVRATAAEGLAVRAVHWEDEAGRSSIEHRADALAAEVRDLPEPWMLLGHSLGALIAAETARRITGPAPELVVLCAAAPPGYPRGFPPRVLTASDAGMAEYVRRLGGTPEEILTHPEFGPQLLAQLRIDLDLIERYEPTYDRPLSSPVSVYGGASDASVPVEVLAGWREFAPQATMRVFAGNHFFLHDSPAEVCRELVADYARTTADRLGG	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	32.18	gnl|BL_ORD_ID|2229|hsp_num:0	2521			2157	2220	bacitracin
BGC0000333.1|Cyclomarin_10 # 10265 # 10756 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0000333.1|Cyclomarin_10 	10265	10756	+	Loose	1750	25.7942	amrB	42.31	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCCGAGTACGCACCGGCCGCCCTGGCCCGGCTCATCCTGTCCGACCGGGCGCGAGATGTGGTCGACGACGCTGTGCGGCTCGTCCCGACGCTCGACGACGGTCAGCGCTCGCCGGGCGACCTGCTGATGGAGGCCCTACGCGTTCGTTCACAGGTCGACAAGCTCGTGACCGCGGCCGTGCTGAACGCCCGCGAACAGGGCGCCAGCTGGTCGGAGATCGCCGTCCTGGTCGGCATCCGCACCGAGTCGGTCACCGAGCGCTGGCTGCCCGACGAGCAGCGCTGGCACGCCGGGCTCGCCCAGCCGATGCGGGAGGAACCCGGCGAGGACCTGCCGTGGCTGGCTGTGCCGCAGGCGGCGTACGCCCCGGAGGTCTACGCCCGCGACCTCGACGGCTGGGCGCTGCGGCACGTCGACGAGATCGAACACGAACGCTGGCGGAAGCTGGGCAGGGACCCCGAGCGCCCGGTCTCCGACGGCCTCGGCTGA	MPEYAPAALARLILSDRARDVVDDAVRLVPTLDDGQRSPGDLLMEALRVRSQVDKLVTAAVLNAREQGASWSEIAVLVGIRTESVTERWLPDEQRWHAGLAQPMREEPGEDLPWLAVPQAAYAPEVYARDLDGWALRHVDEIEHERWRKLGRDPERPVSDGLG	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	15.63	gnl|BL_ORD_ID|428|hsp_num:0	476			1530	1608	
BGC0000333.1|Cyclomarin_11 # 10783 # 12045 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.697	BGC0000333.1|Cyclomarin_11 	10783	12045	-	Loose	700	26.9498	gimA	36.84	3000463	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	gimA family macrolide glycosyltransferase	ATGTACGGGGACACCGAAGAAAGCGCCGGAGTGCATTCGGCAAACAATGTCACTCCGCTGATCAGCACCGATCCGCACGCCGCCTACGAACATCTGCGCGAACAGGCCCCGGCCTGCCCCATCCGGTCCATCGAGGGCTCGCTGATGTGGATCGTCGCGCGACATGACGGCGTCCGTTCCGTACTCGGCGACGCACGTTTCGCGAACAACCCCGCGTCGGTCCCGGGCGGCAAGGCACCCCAGCTGCAGGCCAACGCCATGCGTCGGCTGGGCCTCGACGAGGAGCTGATCCCGTACCTGGCGGACACCCTGCTGGACAGCGACGGCAAGGACCACAACCGGTTGCGCCGCCTGGTGACCCCCGCGTTCTCGGCGCGTAAGGTCAAGGCGCTGGGCCCACGGATCGAGCGCCTCACCGACGATCTGATCGACGCCCTTCCCCAGCACGCCGGCGGCGGGGTGACCGATCTGCTGGAACACTTCGCCTATCCGCTGCCGATCAACGTCATCGGCGAGCTGGTCGGGGTGCCGGCCGCCGACCTGCCGGCGTGGCTGCGCTGGACGCACGACCTCTCGTTCAATCAGCAGGCCCTGGGCCAGACGCTGCGGCCGCTCGTCGACTACACCTACGACCTGGTCCGGCACCGCTATGACGAGCCCGGCGAGGACCTGATCAGCGAGCTGATCCAAGCCCGGGACGCCGACGGCGACCGCCTATCCGAGCGGGAGCTAGTCACCATGGTGCTCAGCCTGGTCATCGCGGGCCACGACACCACGGCCAATTTCATCGCCAACAGCATCTGGGCGCTGCTGACCCACCCGGAGCAGCTCGCACTGTTGCGCGCCGACCCCGGGCTGATGCCGCAGGCCGTGCAGGAGCTGCTGCGCTGGTGCGGGCCGGTGCTGGTGTCCCGGATGCGGTACGCCACCGAGGACGTCGACCTCGGCTGGGGCACGTTCCAGACCGGTGACGCCGTCACGGTGGCGCTCAGCGGCGGCAACCACGACCCTCGCCGGTTCACCGATCCCGGCCGGCTAGACATCACCCGGCAGCACGACACCCGGGGCGAGGTACACCTCTCGTTCGGCGCCGGCCCGCACTACTGCCTCGGCGCGGCGCTGGCCCGCCACGAAGCCGAGATCGCGCTAAGCCGCATGCTGGCCCGGCACCCCGACCTGGCCTTGGCCGTGCCCGCCGAGCAGCTGCAATGGCACGCAGTATCCGGCATGCGCAAGCTCGCCACGCTGCCGGTCCGGCTCTGA	MYGDTEESAGVHSANNVTPLISTDPHAAYEHLREQAPACPIRSIEGSLMWIVARHDGVRSVLGDARFANNPASVPGGKAPQLQANAMRRLGLDEELIPYLADTLLDSDGKDHNRLRRLVTPAFSARKVKALGPRIERLTDDLIDALPQHAGGGVTDLLEHFAYPLPINVIGELVGVPAADLPAWLRWTHDLSFNQQALGQTLRPLVDYTYDLVRHRYDEPGEDLISELIQARDADGDRLSERELVTMVLSLVIAGHDTTANFIANSIWALLTHPEQLALLRADPGLMPQAVQELLRWCGPVLVSRMRYATEDVDLGWGTFQTGDAVTVALSGGNHDPRRFTDPGRLDITRQHDTRGEVHLSFGAGPHYCLGAALARHEAEIALSRMLARHPDLALAVPAEQLQWHAVSGMRKLATLPVRL	MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLFAEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPDLVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARFRGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWRRPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVEVRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRHLPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART	100.72	gnl|BL_ORD_ID|1924|hsp_num:0	1994			285	456	tylosin; oleandomycin; chalcomycin; methymycin
BGC0000333.1|Cyclomarin_12 # 12577 # 13218 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0000333.1|Cyclomarin_12 	12577	13218	+	Loose	575	27.335	LUT-6	37.5	3006948	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	LUT beta-lactamase	GTGCTGGCCCACCTACGTAACGGCGACACCCCGGCCCGGCTGGCCGACGGCTTCGGTGTCAGCCTGACTACCGCATGGCGCTACATCCGCGAAGCGGTGGACCTGCTGGCCGCCACCGCACACACCCTGGCCGAGGCGATGACCAGCATCGCTCGCCTGGCGTACGCCATCCTGGACGGGACCCTGATACCGATCGACCGGGTCGCCAACCAGATGCCGTACTGCTCCGGGAAGCACAGACGGCATGGAGTCAAAGCCCAGGTCATCGCCGACGCGGCCGGGCGGCTGCGGTGGCTGTCCGCGGCGCTGCCGGGCTCGACGCACGACCTGAGCGTGCCCCGCGAGCACGGCATCGTCGAGGCGCTGACCACGGCGGACGTCATGGCCTTCGCCGACAAGGGATATCAGGGCGCCGGTGGCAGCGTCCGCACCCCGTTCAAGCGATACCGCCGCCGGCGTCGGCTGTCCCGCCGGGAGAAGGCGGTCAACCGCGGCCACGCCCGGATCCGAGCGGTCGGCGAACGCGCCATCGCCACCCTCAAGTGCTGGAAACTCCTAACCAAGGTGCACTGCTGCCCGAAACGAGTCACCGCGCTGCTCGCCGCGATCCTCGTCCTTCAACTCGTCGAGGAGCAGCGCTGA	MLAHLRNGDTPARLADGFGVSLTTAWRYIREAVDLLAATAHTLAEAMTSIARLAYAILDGTLIPIDRVANQMPYCSGKHRRHGVKAQVIADAAGRLRWLSAALPGSTHDLSVPREHGIVEALTTADVMAFADKGYQGAGGSVRTPFKRYRRRRRLSRREKAVNRGHARIRAVGERAIATLKCWKLLTKVHCCPKRVTALLAAILVLQLVEEQR	MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTADGAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVSTGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIPGDPRDTSTPQAMAMSLQRLALSDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDKTGTGDYGSANDVAILWPPRRAPVVLALYSALESQQAEARNDVLADAARIVAEWVTG	71.96	gnl|BL_ORD_ID|3689|hsp_num:0	4759			471	636	
BGC0000333.1|Cyclomarin_13 # 13521 # 13712 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.578	BGC0000333.1|Cyclomarin_13 	13521	13712	+	Loose	750	26.5646	blt	29.79	3003006	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCGCTTCTTAGCGTTTCGGGGGCGCTTTCGGCATGGTATTTGATCTTTTTGATGAACTGCCTCATCCTCTTCTCGAAAGAGATGTGGAGACCCAGTGGATCGAGCGGAAATTGCGGCGGCTTCGCGGTGGCCATGGTGGTGTACTGGCCATTGAGGGATCCGCCGGAACGGGCCGGTCCAGTCTCCTGA	MPLLSVSGALSAWYLIFLMNCLILFSKEMWRPSGSSGNCGGFAVAMVVYWPLRDPPERAGPVS	MKKSINEQKTIFIILLSNIFVAFLGIGLIIPVMPSFMKIMHLSGSTMGYLVAAFAISQLITSPFAGRWVDRFGRKKMIILGLLIFSLSELIFGLGTHVSIFYFSRILGGVSAAFIMPAVTAYVADITTLKERSKAMGYVSAAISTGFIIGPGAGGFIAGFGIRMPFFFASAIALIAAVTSVFILKESLSIEERHQLSSHTKESNFIKDLKRSIHPVYFIAFIIVFVMAFGLSAYETVFSLFSDHKFGFTPKDIAAIITISSIVAVVIQVLLFGKLVNKLGEKRMIQLCLITGAILAFVSTVMSGFLTVLLVTCFIFLAFDLLRPALTAHLSNMAGNQQGFVAGMNSTYTSLGNIFGPALGGILFDLNIHYPFLFAGFVMIVGLGLTMVWKEKKNDAAALN	15.75	gnl|BL_ORD_ID|1825|hsp_num:0	1975			891	1032	acriflavine
BGC0000333.1|Cyclomarin_14 # 13754 # 16189 # 1 # ID=1_14;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000333.1|Cyclomarin_14 	13754	16189	+	Loose	390	33.8834	evgA	30.36	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGTACGCCCGGGGGAACGAGTTCGAGGGCGACGTGCCGTTCGGAGCCGTCGCCCAGCTGCTGGAACCGGTCCTCCCCGCTCGGATGGTGGAGGAGTCACCGAGCGTGGCCTCGCCGGCCCTGCTCGGCCGGCTGCGCAGCGACCTGCTGGAGTGCGCGGGCGACCGCCGCCTGGTCCTCGTGGTGGACGACGCCCGCTGGGTGGATGTGCCGTCGCTGCGGTTCCTGAGCTATCTGGGTGCTCGCGCCGAACGCACCCCGGTGCTGCTCGCTGTCGCCCTCGACCCGGCCGATCGGGGCTCGGCGGCCGACTGGCTGGGCAGCGTGAGCACTTCGCTGGAGACGACGCTGCTGCGGCTCGCCCCGCTCAGCGAAGTGGCCACCCGCCGCCTGGTGTCCGTGATGCTCGGGACGGCGAGCTCGCCGGAGTTCGCCGCAGCCTGCTTCGACGCCACCGGGGGCAACCCGTTGCTGCTGCACGAGGTGCTGGCGGAGGCCGCCGCTGGCCGCTCAGGATCGCCCGAGGAGGCGCTGTCCGGACTGTCCCGGCGACCCCCGGTCCGGGTGATGCGCCAGATGGTGCGGCGCTTGCAGAGTCTCCCGCGTTCCTCGGTCGCCGTCGCCCGCGCCGTCGCGGTGCTGGGCGTGGCCGAGGACCCGGTGGTCGTGTCGCGAACCGCGGACTGCCCCGAGGCGGAGGTCGACGACGCGGTGACGGTGCTGGTCGACGCCGAGGTGATGACCGACGGCCCGGCCCTGCGATTTGCGCAACCCATGCTGCGTACCGCCGTGTATGCCGGGATCCCGGCCTTCCTGCGCGGCCGCCTGCACGCCCGTGCGGCGCGCGCGCTGGCCGAGACCGGCGCTCCTTCCGAGGCGGTCGCCGAGCAGCTGGTCAACGTTCCACCCGCCATGGTTCCCGCGGCGGGCGCCAAGGAGCTGGCCGAGCCGCGGTCGAGGAACCGGCGAGCCTCCCGGCACCTGCGCCCGGTCTGGGGCGAGAACCCGGTGGAGCGCGCGGCGGCGGCGCTGGAGGCCGCCCGGACGCTCACCCTCGACTGCCAGTTCGACCGGGCGATCGCGATCCTGGAAGCAGCGATCGCCGACGTGCGCGATCCGGCCCTCAGCCCGCGGCTGGAGGCGACGGCGGTGTGGATCGCGCAGCTTTCCCCGAGCACCCGGGGCCGGGGACGGGCGCGGCTGGATACGCTCGAACGGCCGCACCTCGCGGAGAAGGCGCTGCTGGACCAGATCTGGCGGGGAACGCCGGCCGAACACATCGGACGGCTCACCGGCGATCTGCTGCACCGGCCCCGGATCCCGGCCGGCGACAGCACCGGATGGAGTGCCGGCCTGGTGGCGGCCGTGACGCTCGCGCACTTCGACCGGCTCGCCGAAACTCGGCAGGCAGTACTGACTCTGCGTGATGCGGCGAGCCAGACCCACACCACGCTCGCCGGGCTCGACCTGTGCCTGCGGGCCGCGGTGGACTACCAGCTGGGGGACATCGCCGGGGCCGGAGACCTCGCCCTGCAGGTGCTCTCCGGCACCGACGGGCAGCGCCCGGCCCGCATGGTGCAGGCGTTCGCCGGTGCGGTTCGTGCCGAGACCCTGATCGCGCAGGGCGCGTTGGATGCGGCTGCCGCGATGGTCGAGGAACCGGGCCTGATCGACGACTGCGGGTCGGACACTATCGCCGTCCTTCCGCTGCTGCGCGCCCGCGGCCATCTGCGGATCGCCCAGGACCGGCTCGAGGAGGGCCTCACCGATCTGCTCCGGGGCCGCCGGGCCGCTGCCAGCCTGGGACTGACCCCGGGGGCGTGGGTCGGCTGGTCGTCAGCGGTCACCGCGCTGCACCGGCTCGGGCGTACTGAGGAAGCGCTGTTCATGGCACGGGAGGAGCTGGCCGGAGCCCGGTCCTGCGGCGCGCCCGCGCCGCTCGCCGCCGCGCTGCGCACCCTGGGGCTGCTCACCCCGGGACCGGCGGCTCTGCCCCTGGTGGAGGAGGCGGCCGGTCTGATGGAGGACTTCCCGGGGCAGCTGGAGAAGGCCAGGACCCAGCTGACGTACGGGATCATGCTGCACCGCGTCGGCAAGAGGGCGGCGGCGCGGGAGCAGCTGCGGATGGCTGCCGGGACAAGCGGCGTCCACGGGGCGCACGTGCTGAACCGCCGCGCCATCGATGAGCTGCGCTCGATCGAGGGCGATACCACGGACCGTCGATCCCGGACGGTGCTGACTCCCCAGCAGCAGCGGGTGGCCGAACTCGCCGCCGAGGGCATGCAGAACGAAGAGATCGCGCAGAAGCTGTTCGTCACGGTGAAAACCGTCGAGTGGCACCTGACGCAGGCGTACCGCAAGCTCGGCATCGAGTCTCGCACTGCGCTTTCGCCCGCGCTCGCCGCGACAACCCTGGACTACGCAAAGTCAGCGTGA	MYARGNEFEGDVPFGAVAQLLEPVLPARMVEESPSVASPALLGRLRSDLLECAGDRRLVLVVDDARWVDVPSLRFLSYLGARAERTPVLLAVALDPADRGSAADWLGSVSTSLETTLLRLAPLSEVATRRLVSVMLGTASSPEFAAACFDATGGNPLLLHEVLAEAAAGRSGSPEEALSGLSRRPPVRVMRQMVRRLQSLPRSSVAVARAVAVLGVAEDPVVVSRTADCPEAEVDDAVTVLVDAEVMTDGPALRFAQPMLRTAVYAGIPAFLRGRLHARAARALAETGAPSEAVAEQLVNVPPAMVPAAGAKELAEPRSRNRRASRHLRPVWGENPVERAAAALEAARTLTLDCQFDRAIAILEAAIADVRDPALSPRLEATAVWIAQLSPSTRGRGRARLDTLERPHLAEKALLDQIWRGTPAEHIGRLTGDLLHRPRIPAGDSTGWSAGLVAAVTLAHFDRLAETRQAVLTLRDAASQTHTTLAGLDLCLRAAVDYQLGDIAGAGDLALQVLSGTDGQRPARMVQAFAGAVRAETLIAQGALDAAAAMVEEPGLIDDCGSDTIAVLPLLRARGHLRIAQDRLEEGLTDLLRGRRAAASLGLTPGAWVGWSSAVTALHRLGRTEEALFMAREELAGARSCGAPAPLAAALRTLGLLTPGPAALPLVEEAAGLMEDFPGQLEKARTQLTYGIMLHRVGKRAAAREQLRMAAGTSGVHGAHVLNRRAIDELRSIEGDTTDRRSRTVLTPQQQRVAELAAEGMQNEEIAQKLFVTVKTVEWHLTQAYRKLGIESRTALSPALAATTLDYAKSA	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	397.55	gnl|BL_ORD_ID|936|hsp_num:0	1015			402	570	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000333.1|Cyclomarin_15 # 16321 # 17508 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0000333.1|Cyclomarin_15 	16321	17508	+	Loose	400	26.1794	ErmV	31.71	3002824	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGGCACGGCACCGGCGTACTCGCTGGACGGGGGACGCTCGCTGCATCGGTGGCTGCGGGACATGCGAGAGCATCACCCGGTTCATCGGGAGCTGCTCACTCGCGTGTGGACGCTTTACCGATACCGCGACATCACCCAGGCCACCGCCGATCCGGCCGTCTTCTCGTCGGAGCTGTGGCGGTACCTGCCCGGGGATAGGGGCGACGACGCCCTGACCGCAGGCAACCTGACCGCAATGGACCCGCCCCGGCACCGCCTCGTGCGGGACCTGGTCAGCCGCTCGTTCACGGCTCGCGCGGTGGGCGCGCTGCGGCCCCGGATCGCCGCGATCGCGGCCGAGCTGATCGGCGCCGTCGCCGACCGCGGCGAGATGGACGTCGTCGCCGACCTGTCCGACCCGCTGCCCGTCCTGGTCATCGGGGAGCTGCTCGGCCTGCCGATGGCGGACCGCGAGCTGTTGAGCGACTGGGCGCGGCGCCTGCTCTCCTTCGACAAGGGCGACCTGACCGACGAGGTGGTCCGCAAGCGTGTCGCCGACACTCAGCAGGAGCTGCTGGACTATCTCCGGGTCCACTGCCGGCGTCGCCGGACGAATCCGCAGGACGATCTGATCAGCCGGCTGATCCGGGCCGAGGTTGACGGGCAGCGGCTCACCGAGGACGAGGTGGTCAACTTCGCCAACCTCCTCCTGCTCGCCGGTCACGTGACGACGACGCTGCTGCTGGCGAACATCGTCCTGACACTCGACGAGCACCCCGCCGTGGCGGCGGAGGCACGCGCCGACCGCGGGCTGATCCCGGGACTCATCGAGGAGACCCTGCGATACCGGCCGGTCATCGTCAGCAACATGCGGGTCACCACCCGCGCGGTCACGGTGGGCACAGAGCAGCTACCGGCCGGCCAGCTCGTGTCGCTGTCGTTCATCTCCGGCAACCGCGACGAGCAGTACTTCACCGACCCCGACCGGTTCGACATCCACCGCGACGCCCGCAAGCACCTGGGGTTCGGCCATGGGATCCACTACTGCCTGGGTGCGCCGCTGGCCCGCCTCGAACTGGGGATCGCCCTCGATGCGATGTTCGACCGCTTCAGCCGGATCGAGGTGACGGGCGTTCCCGTCGACTACTACGACACGCCCGGGGTCGCCGGTCCGCGTTCCCTTCGCATCGCCTTCCGTCACCACTGA	MGTAPAYSLDGGRSLHRWLRDMREHHPVHRELLTRVWTLYRYRDITQATADPAVFSSELWRYLPGDRGDDALTAGNLTAMDPPRHRLVRDLVSRSFTARAVGALRPRIAAIAAELIGAVADRGEMDVVADLSDPLPVLVIGELLGLPMADRELLSDWARRLLSFDKGDLTDEVVRKRVADTQQELLDYLRVHCRRRRTNPQDDLISRLIRAEVDGQRLTEDEVVNFANLLLLAGHVTTTLLLANIVLTLDEHPAVAAEARADRGLIPGLIEETLRYRPVIVSNMRVTTRAVTVGTEQLPAGQLVSLSFISGNRDEQYFTDPDRFDIHRDARKHLGFGHGIHYCLGAPLARLELGIALDAMFDRFSRIEVTGVPVDYYDTPGVAGPRSLRIAFRHH	MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSLLAYEIDPRLVPVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLRAPHLTDATLLTQLEYARRRTGDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGIVRIERRRTPLLAPGADAGWRELVDLGFSGAGGSLHASLRRARPRRRVDAAFRAAGLDRDVLVGEVPPWTWLRLHEVLGS	152.51	gnl|BL_ORD_ID|1095|hsp_num:0	1188			45	291	erythromycin; tylosin; oleandomycin; chalcomycin; kitasamycin; carbomycin; celesticetin
BGC0000333.1|Cyclomarin_16 # 17588 # 18382 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.674	BGC0000333.1|Cyclomarin_16 	17588	18382	+	Loose	500	27.7202	CTX-M-85	28.26	3002495	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAAACTCACAGAGGAACAGCTCGCGAGCTACCACAACGACGGGTACGTGCTGCTGGACGACGTGTTCTCCGGCGATGAGATCGAGATCCTGTGCATCGCATTGAGCGAGGACCAGCGGGTGCCGGGTCCGCATCTGATCACTGAGAACGATGGATCCACCCTGCGCTCGATCTACGCCTCGCACACCCGTCACCCAGTCTTCGAACGGCTTGTGCGCACCGAGCGGCTGCTCGGCCCGGCCCGGCAGCTCGCCGGGGAGGATCTGTACGTCCACCAGATGAAGATCAACTCGAAGCAGGCGTTCGGCGGCGAGCGATGGGCGTGGCACCAAGACCACATCGTCTGGCGGGACGTCGACAACATGCCGGCCCCCTCCCAAGTGAACGTGGCGCTCTTCCTCGACGACGTCACCGAGTTCAACGGCCCCGTGATCTTCCTGCGTGGCTCGCACCAGCTGGGACCGCTGGAACGCCCAGGGTCCACCGAGGGCCACGAATCCGGCCACATCGACCCGGACGAGTACTCGCTGACCCCGGCCGAGCTGGCCGACCTGGTCAAGCAGCACGAGATGGTCAGCCCGAAGGGCGCGCGCGGCGGGGTGCTGCTGTTCAGCTCGCAGATCGTCCACGGGTCCGGCACCAACATCTCGCCGTTCGCCCGCCGCCTGCTGATCCTCACTTACAACCCGGTGTCGGACGCGCCGCGCCCGGTCGGCGCCCCGCGCGCGGAGCACCTGGCCGGCCGCGACACCTCCCCGCTCGTGGTCGACAGCGGTCCACTCGACCGCCGCTGA	MKLTEEQLASYHNDGYVLLDDVFSGDEIEILCIALSEDQRVPGPHLITENDGSTLRSIYASHTRHPVFERLVRTERLLGPARQLAGEDLYVHQMKINSKQAFGGERWAWHQDHIVWRDVDNMPAPSQVNVALFLDDVTEFNGPVIFLRGSHQLGPLERPGSTEGHESGHIDPDEYSLTPAELADLVKQHEMVSPKGARGGVLLFSSQIVHGSGTNISPFARRLLILTYNPVSDAPRPVGAPRAEHLAGRDTSPLVVDSGPLDRR	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTPAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	90.72	gnl|BL_ORD_ID|1195|hsp_num:0	1304			336	474	
BGC0000333.1|Cyclomarin_17 # 18411 # 41780 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000333.1|Cyclomarin_17 	18411	41780	+	Loose	1000	139.428	almE	26.87	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGAAGTGAGCATGAGCTCTGCTGACGTAGCGGCCACCATCGTCCGGTTGTACGAGTCGGCGGTCGAGGCGCACCCCGACAAGCCGGTGATCAACGACGGCCACCGCGTGTGGTCGTACCGGGAGCTGAACTCGGCGGCCAACCGCATCGCGTGGTGGCTGATCGGGCGCGGCGTCGGGCCTGAGCAGACGGTGGGTGTCGCCCTCGACCGCGGCATCGACCAGATCGCCGCGCTGCTCGGCACGCTCAAGGCGGGCGCCGTCTATCTGCCGCTCGATCCGGTCCTGCCGGCCGAGCGCATCAACTACCTGCTGGCCGACGCCACGCCCAGCCTGATCCTCGACGGCGATGCCGCCGCCTCGGCCGGGCAACCGGAAGACACTCCGGCGGTGCCGCTCACCTCGGACAGCCTGGCGTACGTCATCTACACGTCCGGCTCTACCGGGACGCCGAAGGGCGTCGGCGTCACGCACGGCAGCATGGTCAACCTCGCTCGCACGGTCACCGGCCAGTACGCCCTGGGCGACACCCCGCGCGTGCTGCAACTGGCGTCGCTCGGCTTCGACGTGGCCATCTGGGAACTACTCACCGCAGTGGCCACCGGCGGCACCCTGGTCGTCAGCCAGGCCGACCAGCTCTCCGGCGATGACCTGCTCCGGGTGCTGCGGGAGCAGCGGATCACGCACGTCACGCTGCCCGTTCCGGTGCTGGCCTCGCTCCCGCCGGACGCCGAGAATCAGCTTCCCGACCTGACCACGGTACACATCGGCGGGGAGACCTGCCCGCCCGAGCTGGTGCGGCGGTGGTCGGCGGGCCGCCGGCTGATCAACGGGTACGGCGCGACCGAGACCACCGTGGCCGCCACCCTCACCCCGCCACTGACCGGCCCGGACGCCCCGATCGGCAAGGCCATCGACGGCACCCGCGTCTATGTCCTGGACGACACGCTGGCGCAGGTCGTCCTGGGAGCGGCAGGCGAGTTGTACGTCGCGGGCGCCAACGTGGCCCGGGGCTATCTGCGCCGGCCGGGCCTGACCGCGTCCCGGTTCCTCGCCGATCCGTACGGGCCGCCCGGGTCGCGGATGTACCGCACCGGCGATGTCGGCCTGATCCGCCCCGACGGGCAGCTGGAGTTCCTGCGCCGCGCCGACGACCAAGTCAAGATCCGGGGAGCCCGGGTGGAGCCCGGCGAGCTCGAGGCAGTGCTGCAGCGCCGGACCGACGTCGTGCACGCGGCCGTCACCGTACGCCCGGACGCCCGCGGTGAACGACAGCTCGTTGCCTACGTCGTTCCGGCCGCGGCCGCCACCGGCGCGGCGGAACTGCGCGACGACCTGCGCGGCACGCTGCCGTCGTACCTGGTCCCGTCCAGTGTCGTGCTGCTCGACAGCCTGCCGCTGACCCCGAACGGCAAGGTAGACCGTGACGCACTGCCCGACCCGGAGTACGCTCCGGCCGGACTCGACCGGACCGCGCGCAGCCCGCTCGAGGACATGCTCCGGGTGGTGTTCGCCGAGATCCTCGAACTGCCGCAGGTGGGGTTCGACGACGACTTCTTCGACCTCGGTGGGCACTCGCTGCTGGCCGGCCGGTTGATCGGCCGGATCCGCGGCACCCTCGGCCTCGAGGTGCACATGAAGGACTTCTTCGAGAAGTCCACCCCGGCCGCCCTGGCGTCGTACCTGCAACGGCAGGAGACCGGCCCGGCCCGCCCGGAGCTGACCCGCCTGCCTCGGCCCGACCGGATCCCGCTTTCCTTCGCGCAGCAGCGGCTCTGGTTCCTGCACCGCCTGGAAGGGCCGTCGGCGACCTACAACATGCCGCTCGCCCTGCACCTGACCGGGAAGGTCGACACCGGCGCGCTGGCCGCGGCCCTCACCGACGTCATCCGCCGCCACGAGCCGCTGCGCACCCTCATCCGCGAGGTCGACGGTCAGCCGTACCAGCAGATCCTGGACCCGGAGGAGGTACGCCCGGCCCTGCCCGTCCGTCAGGTCGGCGCGGCGCAGCTGGACGAGGAACTGCGCCGGTCGGCACGGCACGAGTTCGACCTGGCCCGGCAGATCCCGGTCCGCGCCGAACTGCTCACCGTCAGCCCGGACGAGTCCGTACTGATGCTGGTCATCCACCACATAGCCGGCGACGGCTGGTCCGGCGCACCCCTTGCCCGGGACCTGGTCACCGCCCACTCGGCCCGGCTCACCGGGGTTGCACCGCAGTGGCCACCGCTCCCGGTCCAGTACGCCGATTACACGCTCTGGCAGCGCGCCATGCTCGGTGGCGAGGAGGAGCCGGCAAGCCCGCTGAACGAGCAGCTGCGGTACTGGCGTGAGCAGCTCGCCGACCTCCCCCACGAGATCACTGTGCCGGGCGACCGGCCTCGCCCGGCCGTCGCCACCTACCGCGGCGGCGTCGTCCCGATCACCATGGACGCCGACCTGCACGCCGGCATCACGGAGCTCGCCCGCCGCAACGGCGCCACCGTCTACATGGTCCTGCAGTCAACCGTGACCGCGCTGCTCACCCGGCTCGGCGCGGGCACCGACGTCGCCATCGGTGCCGGCGTCGCCGGACGGTCCGAGCCGGCCCTCGACGATCTGGTTGGGCTCTTCGTCAACATGCTGGTGCTGCGCACCGACACCGCCGGCTCACCGCGGTTCACCGAACTGCTGCAACAGGTGCGGGACACCAGCCTCGGGGCGTACGGCCACCAGGACATCCCATTCGAGCAGCTGGTCGAGAGTCTCAACCCGCATCGGGTCGCCGGCCGCCAGTCGCTGTTCCAGGTCGCCCTGGTCCTGCAGAACAACACCTCTGTCCCGTTCGACCTGCCCGGCCTGCGGGTACGCGCGGAGCAGATCCCGACCGGGACCGCCCGGTTCGACCTCTCGCTGAGCGTCACCGAGCACGGGGACGGAATCAGCGGAACCGTGGAGTACGCCGCTGACCTCTACGACCGCGCGACGGCGGAGGCTGTCGTCGAGCGCTGGATCCAGTTGATCCGCCAGGTGGTGGCGGATCCGGCCCGCCGGGTCGACACGCTCGACGTCACCACCCCCGGCGACGAATCCCGGCTGGCCGGGTGGCGGCGGTACGAGCGGGACGTCCCGCCGGTGACCTTCGGCGACCTGTTCGCCCGGCAGGTGGCTGCCACGCCGGACGCGATCGCCGTGAGTGACGGCGGCGACGTGTGGACGTACCGCGAGGTGAACCGGTACGCCAACCACGTCGCGGACCGGCTGATCGACCGAGGTATCGGCCCGGAGGACTTCGTCGCCGTCGCCATGCCGAGGTCCGCGCGCCTGGTGGCGTCCCTGCTCGGGGTACTCAAGGCGGGTGCCGCGTATGTGCCGGTGGACCTGGTCTTCCCGGCTCGCCGCAACCGGCACGTGATCATCGACTCGAACCCGCGGCTGGTGCTGACCTCCCGTGCCGGCGCCGAGAACCTGCCCGCCGACCTGCCCTGTGAGCTGGTCATGATCGACGCCTGGGGTACCGGCCGGGAGGACGGTCCGGCCGACGCCGACCGGGTGCGGCCCTCGAACGTCGACAGCCCGGCGTACGTCATCTACACCTCCGGCTCGACCGGGCAGCCCAAGGGCGTCGTGGTGACCCACCGCGGCCTTGCGGCCTTCGCCGAGACTCTGCGGGAGCGGTGTGCCGCGGGACCGAACGACCGGGTGCTGCAGCTGTCGTCACCCAGTGTGGACGCCTCGGTGCTGGAGATGGTGTGGGCGTTCAGCTCCGGGGCCCGGCTAGTCATCGCCAGCCAGTACCGGCTGGCCGGCGAGGAGCTGGCTCAGGCGCTCGCGGAGCAGCGAATCACCCACGCGCACATCCCGCCGTCGGCGCTGAGCACCATCCCGGCGGAGGCTGCCGGACGGCTTCCCGAGTTCCGGAGGCTCAGCGTCGGCGCCGAGTCCTGCCCGTCCGAACTGGTCCGGCTATGGCTGCCGGGGAGGGACTTCGTCAACGCGTACGGCCCGACCGAGTGCACGGTCGCCGCCTCGCACACTTTCCCGCTGGCCGAGGCGCGCGCCCCGATCGGCCGGCCGGTCATCGACGCCGAGCTGTACGTGCTGGACGAGACGCTCCGGCCGGCGGCTCCTGGCGTGCCCGGTGAGTTGTACATCGGTGGCGCCGGCCTGGCTCGGGGCTACCTGCGCCGGGGTGGGCTGACCGCGTCGCGGTTCGTCGCGAACCCGTACGGCGAGCCGGGGTCACGGGTGTACCGGACCGGCGACGTCGTCCGGTGGAACACGGACGGCGAGCTGGAGTACCTGGGGCGCTCCGACGAGCAGGTGAAGGTCCGCGGCTTCCGGGTCGAGCCCGGCGAGGTCGAACGCGTCCTCGCGAGCCAGCCGTCGGTCGACCGAGCCGTGGTGGTGCCCCGCCGGGACCGCTCGGGGGCCGTCTCCCTGGCGGCGTACGTGGTGCTGGCGGCGGCGTCACCGGCCGGCTTCGACGATCAGCTGTCCGAGTGGAACGACATCTACGACCAGGTCTACGCCGGTTTCTCCGGTGACGCGGGCAACGACTTCATCGGCTGGACCAGCTCGTTCACCGGCGGCCCGATCCCGATCGAGGAGATGCGGGAGTGGCAGCGGTCCGCGGTCGACGCGGTGCGGCGCTTCGGGCGCGGCCGGGTGCTGGAGATCGGCTCGGGTTCCGGCCTGCTGATGACCCCGCTGGCCGACGCCGTCGACGAATACTGGGGCACGGACCTGTCTGAGATCTCGATCGACCGGCTGCGCGCCTTCGCGGACGCCCGCAGGTGGAACCACGTGCGGCTGTCCTGCCAGCCGGCGCACGACGTCTCCGGCCTGCCCCGCCGCTACTTCGACACGGTCGTCATCAACTCGGTGGTGCAGTACTTCCCGAGCGCTGACTATCTGCGCGACGTGCTCGCCAAGGTCGTTGACCTGCTCGCCGACGGTGGCCGGGTCATCGTCGGCGACGTCCGGCACTACGGCCTGCTGCGGGTGTTCCACGCGGCGGTGCACGACTTCCGTGGCACCGAGGGGCTGCGCGCGGCGGTCGAGCACGCCATGGCGGTGGAGAAGGAGCTGCTGCTGGCCCCCGAGTTCTTCACTTCGATCGACCACCCGGCCGTCACCGGTGTCGAGGTGACGCTCAAGGCCGGGCAGGCGTCGAACGAGCTGACCGGCTACCGGTACGAGGTCGTCCTGCACACCGCCCCGGCGCGGCGGCTCACGACGCTGCCCGTGCTGGTGTGGGGCCGGGACACCACCGACCTGGACGAGGTGACCGGCCCGGCGCGGGTGACCGGCATCCCGAACCCGCGGCTGGCCGGCGGGGTGGCCGCGGTGCGGTTGCTGGACGGTATGGACGCGGTGCCCCCGGCGGCGGGCCCGGAGCTTGAATCCGAGGCGGTGCGCCGGTGGGCGGTCCAGCGCGGCATGCGGGCGGTGCCGACGTGGTCGTCGAACCGCTGGAACACGTACGACGTCGTGCTGATCCACGCCGCCGAGGCGGAACCCCTGGCCGACGTGTACCGCCCGGCCGACGGCGTCGAGCCGGCCAACGTCCCCGAGGTCGCCCGCACGGCCGGCAAGCTGGTGTCGGAGTTGCGCTCGACGGTGCAGGGGTTGCTGCCGGACTACATGGTCCCGGCCACGATCACCCCGATCGAGCGGATCCCGGTCACTCCGAACGGGAAGATTGACCGCCGGGCGCTGCCCGACCCGGAGGTGGTGCTCTCGCGCGGACGCCACGCGCGAACCCCGCTGGAGCAGATCCTCTGCGAGCTGTACGCCGACATCCTCGGCCTTGAGCGGGTCGGCGTCGACGACAGCTTCTTCGATCGGGGCGGGCATTCGCTATTGGCCACCCGGCTGACCAGCCGGATCCGCTCGGTGCTGGGCGTCGAGGCGCTGCTGCAGCAGGTCTTCGCGGCGCCGTCGCCGGCCGAGCTGGCGGTGGTGCTGAGTGAGCAGCAGGGCCGGGTGCAGCAGGCGCTGGAGCCGGTGGCGCGGCCCGAGGTGCTGCCGTTGTCGTTCGCTCAGCAGCGCCTGTGGTTCTTGCACAAGCTGGAGGGGCCGTCGGCGACGTACAACTCGCCGTTGGCGTTGCGGCTGTCGGGCACGCTGGAGGTGACTGCGTTGCGGGCGGCGCTCGGCGACGTGGTCGGCCGGCACGAGGCCCTGCGGACCGTGTTCGCCGAGACGGACGGTGTGCCGTATCAGAAGGTCCTCGACGTGGCGGACGTCGACCTGTCGGTGCGTGAGGTGGCCGCCGACGAGCTGCCGGGGGTTTTGCGGGACGCGGCCCGGTACGAGTTCGACCTGGCACGTGAGATCCCGGTGCGGGCGTGGCTGTTCGCGGCTGGTCCGGGCGAGTGGGTGCTGATGCTGGTGTTGCACCACATCGCGGCGGACGGCTGGTCGCTGGGGCCCCTGGCGCGGGACCTGGCGACGGCGTATGCGGATCGCCGGATGGGTCGGGGGCCGTCGTGGTCGCCGTTGCCGGTGCAGTACGCGGACTACACGTTGTGGCAGCGGCGGCTGCTCGGTGACGAGGCCGATCCGGACAGCGTGTTCGGGCGTCAGCTGGCGTACTGGCGTGGGCAGTTGGCGGGGCTGCCGCAGCAGGTGACGTTGCCGACTGATCGGCCCCGGCCGCAGACGGCGTCGTATGCCGGTGACGTGACCATGTTCCGGCTGGATGCCGGGCTGCACGCAGATCTGCTGCGGCTGGCCCGGACGTCGGGAGCGACGTTGTTCATGGTGTTGCAGGCGGCGTTGGTGGCGGTGCTGACGCGGCTGGGCGCGGGCGATGACGTGCCCCTCGGTAGTCCGATTGCTGGTCGTAGCGATGATGGGTTGGACGATCTGGTCGGGTTCTTCGTCAACACGTTGGTGTTGCGGGCCGACACGTCCGGGAATCCGGGCTTCGATGAGCTGCTGGAGCGCGTCCGCGACACGTCGCTGGAGGCGTACGCCCATCAGGATGTGCCGTTCGAGTTTCTGGTGGAGAAGCTCAACCCGCACCGCAGCACCGCGCACAGCCCGTTGTTCCAGGTCCTGCTGGCGTTCCAGAACAACTCGGACACCAGCTTCCACCTGCCCGGCCTGCGCGCCGAGCGGGAGGAGATCGGCACCCGCGTGTCCCGGGTGGACCTCACCCTCAACATCACCGAGGCGTTCGGCGTGAACGGCGCGCCGCAGGGCATCCGCGGCGCGGTCGAGTACGCCACCGACCTGTACGACGCCCGCACCGTCGAGTCGTTCGCGGCACGGTTCGTGCGCATGCTGCAGGCGGCCGTCGCCGACCCGAGCCGCCGGATCAACGCCGTCGACCTGCTCTCCGACGAGGAGAACGCGACAGTTCTCGCCCTGTCCGGGCGGGACGCGGCGGTCCCCGAGTCGCGGGTGTGGCCGGCCGTCTTCGAGGCCACGGCCGCCGCTGCCCCGGACGCGACCGCCGTGGTCGAGGGGCAGCTCAGCTGGACGTACGCGCAACTGAACGCGAACGCGAACCGGCTGGCCAGATATCTGATCGACCGCGGCGTCGGGCCCGAGGACGTCGTCGGCGTGCTGATGCCGCGCAGCGCGATGCAGATCGCCACCGTGCTCGCGATCGGCAAGGCCGGCGCCGCGTTCCTGCCGATCGACCCGGCGTACCCGGCGGAACGGGTCGAGTACCTCATCGCGGACGCCCGGCCGAAGATGCTGCTCGCCGACACCGCCCACGTGGGGGTGGCGGCCGGTGCCATCGCGATCGACGAACCCGCCGTGGCCACCGCGCTGCGGGAGGCGCCGGTGACCGACCCGGCCGGCGTCGCCGTGCGGCTCGAACACCCGGCCTACGTCATCTACACCTCCGGCTCGACGGGCCGGCCCAAGGGCACGATCGTGACCCACAGCGGCCTGGCGGCGCTGGCAGTCAGCGGCTGCGAGCGGGCGGCTGTCGACCGGGACAGCCGGGTCCTGCAGCTCACCTCGCCGAGCTTCGACGTCTCCGTCTTCGAGTTCCTCGCCGCGTTCCACGCGGGGGCCGTGCTGGTGATGCCCGAGCCCGGCCGGCTGGCCGGCGAGGAGTTGGCGGAGCTGCTTGCGGATGCGGGCGTGTCGCATGCCTTCGTGCCACCGTCGGTGCTGGCGACTCTGCCGGATGAGGCCCCCGGACGACTGGCCGGGCTGCGGAGTCTGGTGGTCGGCGGGGAGGCGTGTTCGGCGGATCTGGTCCGGCGCTGGTCGGTGGGCCGGCGGATGACGAACCTCTACGGCCCGACGGAGACCACGGTGGCGGCGTCGATCAGCCGCCCGATGTCGACCGGCGCCCACCCGATCGGCGCTCCGCTGCCGGGTACCCGGGTGTACGTGCTCGATGCGAACCTGCGCCCGGTCCCCCCGGGCGCGCGCGGCGAGCTGTACATCAGTGGCATCGGAGTGGCCCGGGGATACCTCGGCCGCCCGGTCCTGACCGCATCGCGGTTCGTGGCCGACCCGTTCGGCCCGGCGGGCGCCCGGGCGTACCGGACCGGTGATGTGGTCCGGTGGAACGCCGACGGCGAGCTCGAGTACTTCGGCCGGTCCGACCACCAGCTCAAGATCCGTGGCTTCCGGGTGGAGCCCGGCGAGATCGAGGCCGCGCTGGTACGGCGGCCGAGCGTCGCGCAGGCCGTCGTGGTCGCCCGGCCCGATCAGCACGGCTTCCAGGCGCTGTACGCCTATGTGACGGCCGGTGCGGAACCCGCCGACGCCGCCCGCCTGCGCGAGGAACTGCGCGCCGAGCTGCCCGACTACCTGGTGCCGGCCGCGATCGTCGTGCTCGACGAGTTTCCGCTCAACGCCAACGGCAAGCTGGATCGCAATGCGCTGCCCGAGCCGCGGTTCGTCACCTCGGCCGCGGACATCCGGTCACCGGGCATGCCGCAGGAGGAGATCCTGCGATCCGTGTTCGCCGACGTCCTGGGGATCGAGCGGATCAGCGCCGACGACAACTTCTTCGACCTGGGTGGGCACTCGCTGCTGGTGACCCGGTTGATCTCGCGGGTGCGCGGCACGCTCGGCGTGGACGTATCGATGCAGACGTTCTTCAACGCTCCGACCCCGCGGCAGCTCGCCGGTCAGCTCCTCGAGGGCGGCCCGGTGCCGGCCCGGTTGCAGCCGGTGCCACGGCCTGAGGCGCTGCCGCTGTCGTTCGCCCAGCAGCGTCTGTGGTTCCTGCACAAGCTGGAAGGGCCGTCGGCGACGTACAACTCGCCGCTGGCGATCAAGCTCTCCGGCGAGCTGGACGTGGACGCGCTGCGGCTGGCGCTGGCGGACGTCGTCGTCCGGCACGAGGCGCTGCGGACGGTCTTCGCCGAGCGGGCCGGGAACCCGTATCAGCGGATCCTGGACTCCGCGGAGGTCGAACTGCCCGTTCGTGAGGTGCCCCAGTCGAAGTTGCCGGACGCGTTGCGCGAGGCGGCCCGATACGAGTTCGACCTTGCACGGGAGATTCCCCTGCGGGCGTGGCTGTTCACGGCCGGGCCGGGCGAGTGGGTGCTGATGCTGGCGCTGCACCACGTTGTCGCCGACGGCTGGTCGCTGCAGGTGCTCGTGTCCAACCTAACCGCCGCGTACACCAGCCGGCGGGCCGGACACGCGCCGTCGTGGCAGCCGCTGCCCGTGCAGTACGCCGATTACACGCTCTGGCAGCGTAGGCACCTGGGCACCGAGGACGACCCGGACAGTGTGTCCAGCCGGCAGGTCTCCTACTGGCTGGAGCAGCTGGCGGATCTGCCCGACCAGGTGACGCTGCCGACCGACCGGCCGCGCCCGGCGGTCGCCAGCTACCGCGGCGAGACGGTCACCTTCGACCTCGACGCCGAGGAGCACGCCGAGCTCGTCCGCCTGGCCCGGGAGACCGGCACCACCCTGTTCATGATTCTGCAGGCGGCCCTGGCCGGCCTGCTCACCCGGCTCGGGGCCGGAACCGACATCGCGATCGGCTCGCCCATCGCCGGACGCACCGACGACCGTCTCGAAAACCTGATCGGTCTGTTCGTGAACATGCTGGTGCTGCGCACCGACACCGGCGGCGATCCGACCCTGGGCGAGCTGCTCACCCGGGTGCGGGAGACCTCTCTGGCCGCGTACGCCCACCAGCACATGCCCTTCGAATACCTGGTGGAACGGCTCAATCCGCACCGCTCGGCAGCCCACCATCCGCTGGTGCAGATCCTGTTCGGACTGCAGAACACCGCCGAGCAGAATGTCAGCCTGCCGGGCGTCACCGCCTCCGGCATGTCGGTCGACACGGGCGTCTCCCGGGTGGACCTGTCGATCAACATCGTCGAGGCTTCGGCGCCGGACGGCAGCCCGGCCGGTCTCACCGGTCTCGTCGAGTTCTCTACTGATCTGTATGACCGGGCGACGGTCGAGGCGTTCGCGGCTCGGTGGGTGCGGGTGTTGCGGGCGATGGTGGTGGCGCCGGGGTCGCGGTTGAGTGGGGTGCAGCTGCTGGGTGCCGATGAGCGGGTTCGGTTGTTGCAGCGGTGGGGGGCGGCGTCGGGTCCGGTGGCGGCGGTGACGCTGGCGGAGTTGTTCGAGCGTCGGGTGGCGGCCAGGCCGGATGCGGTGGCGGTTGTCGAGGGGGAGGTGAGCTGGTCTTATGCGCGGCTGAATGCGTACGCGAACCGGGTTGCCTGGTCGTTGGTCGAGCGCGGAGTGGGTGTCGAGGATGTGGTGGCGGTGGTGCTGCCGCGCGGCGCGGTGCAGGTTGCGACGGTGTTGGGTGTCGTCAAGGCGGGTGCGGCGTATCTGCCGGTGGATCCGAGTTATCCGCGGGCTCGGGTGGAGTATTTGTTGCAGGACGCCGGTCCGGCGTTGGTGATCGGTGAGTCGGATGTCTTCGACGGGCAGCCGGAGCACGATCCGGTGCGTCCGGTGCCGGTGGACGCCGCGGCGTATGTGATCTACACGTCGGGTTCGACGGGGCAGCCCAAGGGTGTCGTGGTGACCCACCGCGGGCTCGCGAGCATGGCCGCGACGCAGCAGCGACTCGGTGCGGGCGAGGGCTCACGGGTGCTGCAGTTCGCCGCGCTCGGCTTCGACGCCACGGTGTGGGAGCTGGTGATGGCCCTCGGCGCCGGCGCCGCCCTGGTGGTGCCCAAGACCGACCAGCTGGCCGGGGAGGACCTGGCGGCCGTCCTGCGCGAGCAGCGCATCACCCACCTGACGCTGCCGCCGACCGTGCTGGCGACGGTGCCGGCCGACCGGCTGCCCGACCTCGGCACCCTGGTGGTCGCCGGGGAGGCGTGTCCGCCCGAACTGACCGCGCGGTGGTCGCCCGGACGCCGGATGTTCAACGCGTACGGCCCGACCGAGTCGACCGTCTGCGCATCGATCAGCGCGGAGCTCTCACCCGGCCTGGCGCCGATCGGCGGCCCGGTGCTGAACACCCGGCTCTATGTGCTGGATGATGCGCTTCAACCGGCGGCGTCCGGGGTTCCGGGCGAGCTTTACATCGCCGGCGAGGGCTTGGCCCGGGGCTATCGGGGCCGCGCCGGTCTGACCGCGACCCGGATCCTGGCCGATCCCTACGGGCCTGTCGGGTCGCGGATGTACCGCACCGGCGACGTGGTCCGCTGGAACGCCGACGGGGACCTGGAGTACCTCGGCCGCTCCGACGAGCAGGTGAAGATCCGCGGCTTCCGGGTGGAGCCGGGCGAGGTGGCGTCCGTGCTGCTGCGCCATCCCGCGGTCGCCCAGGCCGCCGTCATCGTCCGGCTGGAACAGCTTCTCGCGTACGCCGTTCCGGCCCTCGGGCGGGCGGTCCGCGACGGAGAGCTGCGCGCGTACCTGCAGGACGAGCTGCCGGAGCACACGGTTCCGTCGGCGGTCGTCCTCCTCGACGAGATTCCCCGCACCTCGCACGGGAAGGTCGATCAGCGGGCGCTGCCGGACCCCGAGCAGGCCGGCGGCCGGGGGCGCGCACCGCGTACGCCGCAGGAGGAGCTGCTCTGTGTCCTGTTCGCGCAGGTGCTCGACGTGCAGCAGGTGGGCCCGGACGACAGCTTCTTCGATCTGGGTGGGCATTCGCTATTGGCCACCCGGCTGATCATTCGAATCCGCAGGGCGTTCCGCTGCGAGCTTCCGCCGCGCGCGCTGTTCGCGGCGCCGTCGCCGGCCGAGCTGGCGGTGGTGCTGAGTGAGCAGCAGGGCCGGGTGCAGCAGGCGCTGGAGCCGGTGGCGCGGCCCGAGGTGCTGCCGTTGTCGTTCGCTCAGCAGCGCCTGTGGTTCTTGCACAAGCTGGAGGGGCCGTCGGCGACGTACAACTCGCCGTTGGCGTTGCGGCTGTCGGGCACGCTGGAGGTGACTGCGTTGCGGGCGGCGCTCGGCGACGTGGTCGGCCGGCACGAGGCCCTGCGGACCGTGTTCGCCGAGACGGACGGTGTGCCGTATCAGAAGGTCCTCGACGTGGCGGACGTCGACCTGTCGGTGCGTGAGGTGGCCGCCGACGAGCTGCCGGGGGTTTTGCGGGACGCGGCCCGGTACGAGTTCGACCTGGCACGTGAGATCCCGGTGCGGGCGTGGCTGTTCGCGGCTGGTCCGGGCGAGTGGGTGCTGATGCTGGTGTTGCACCACATCGCGGCGGACGGCTGGTCGCTGGGGCCCCTGGCGCGGGACCTGGCGACGGCGTATGCGGATCGCCGGATGGGTCGGGGGCCGTCGTGGTCGCCGTTGCCGGTGCAGTACGCGGACTACACGTTGTGGCAGCGGCGGCTGCTCGGTGACGAGGCCGATCCGGACAGCGTGTTCGGGCGTCAGCTGGCGTACTGGCGTGGGCAGTTGGCGGGGCTGCCGCAGCAGGTGACGTTGCCGACTGATCGGCCCCGGCCGCAGACGGCGTCGTATGCCGGTGACGTGACCATGTTCCGGCTGGATGCCGGGCTGCACGCAGATCTGCTGCGGCTGGCCCGGACGTCGGGAGCGACGTTGTTCATGGTGTTGCAGGCGGCGTTGGTGGCGGTGCTGACGCGGCTGGGCGCGGGCGATGACGTGCCCCTCGGTAGTCCGATTGCTGGTCGTAGCGATGATGGGTTGGACGATCTGGTCGGGTTCTTCGTCAACACGTTGGTGTTGCGGGCCGACACGTCCGGGAATCCGGGCTTCGATGAGCTGCTGGAGCGCGTCCGCGACACGTCGCTGGAGGCGTACGCCCATCAGGATGTGCCGTTCGAGTTTCTGGTGGAGAAGCTCAACCCGCACCGCAGCACCGCGCACAGCCCGTTGTTCCAGGTCCTGCTGGCGTTCCAGAACAACTCGGACACCAGCTTCCACCTGCCCGGCCTGCGAACAAGACTGGAGGGGGTCAGCACCGGACTCTCCCGTGTGGACCTGTTCATCAGCCTCGCGGAGCAGCCGGATGCCGGCGGCGTGATCGGGGCCGTCGAGTACGCCACCGACCTGTACGACGCCGCGACGGTCGAGGCTTTCGTCGGCCGCTGGCTGCGGTTCCTGGCCGCCGTCGCGCACGATCCGGAGCAGCGCATCGGGTCTGTGGACCTGCTGCTCGACGGCGAGCGGGAGCGGCTGACCGGCTGGGCGTACACCGAGCCGGAGGTGGAGCCGGCCACCCTGTCCGAGCTGTTCGAGCGTCGGGTGGCGGCCAGGCCGGATGCGGTGGCGGTTGTCGAGGGGGAGGTGAGCTGGTCTTATGCGCGGCTGAATGCGTACGCGAACCGGGTTGCCTGGTCGTTGGTCGAGCGCGGAGTGGGTGTCGAGGATGTGGTGGCGGTGGTGCTGCCGCGCGGCGCGGTGCAGGTTGCGACGGTGTTGGGTGTCGTCAAGGCGGGTGCGGCGTATCTGCCGGTGGATCCGAGTTATCCGCGGGCTCGGGTGGAGTATTTGTTGCAGGACGCCGGTCCGGCGTTGGTGATCGGTGAGTCGGATGTCTTCGACGGGCAGCCGGAGCACGATCCGGTGCGTCCGGTGCCGGTGGACGCCGCGGCGTATGTGATCTACACGTCGGGTTCGACGGGGCAGCCCAAGGGTGTCGTGGTGACCCACCGCGGCCTGGCCGCGCTCGCCACCGGCACGGTCGGCCGCAACGCCGTCGCCGGCGACAGCCGGGTGCTGCTGCTGGCGTCGCCGAGCTTCGACGCCTCGGTCCTCGAACTGATGATCGCCATCGGCGCCGGTGCGGCCCTGGTCGTCTCCCGCGAGTCGCGACTGGCCGGCGAGGAGCTGGCCACGCTGATCGCGCAGGCGCGGGTCACGCACGCGTTCGTGCCGCCGTCAGTGCTGGCGACCTTGCCCGGGGCGGCCACCGGGGAGCTGCCGGCGTTCCAGGGCTTGGTGGTCGGCGGCGAGGCGTGTTCGCCCGACCTGGTGCGCCGCTGGTCGGCGGGCCGGCGGATGACGAACCTGTACGGCCCGACGGAGACGACGGTGGCGACGACGGTCAGCCGACCGTTGTTCGGAGAGGCGCATCCGATCGGCGCCCCGCTGCCCGGATGGCGGGTGTACGTGCTGGACGCGGGTCTGCATCTGGTTCCGCCCGGGTCGCGGGGTGAGCTGTACATCGGTGGCGTCGGCCTGACCCGGGGCTACCTGCGCCGGGCTGGCCTGACGGCGTCGCGGTTCGTGGCCGATCCGTTCGGCCCGGCCGGTGCGCGGATGTACCGCACCGGTGACGTGGTCCGGTGGAACGCCGACGGGGAACTCGAATACCTGGGCCGTTCCGACCACCAGGTTCAGATCCGGGGTATCCGCGTCGAGCCGGGCGAGGTGCAGGCCGCGCTGACGGCACATCCGGATGTGGCGCGCGCGGTCGTCGTGGTCAGCGACGATCGGCGAGGTGACCCTGCGCTGGTCGGTTACATGGTGCCCGAGCGGCCCGGCGCCGACCCTGCGGCCGTCCGCGAGGATCTGCGCCGGATCCTGCCCGATCACCTGGTGCCGGTCGCGATCGTGGTGCTGCCGGAGATCCCGCTGACGCCGAACGGCAAGCTCGACCGGGACGCGTTGCCGGATCCGGAGTACGAGACCTCGCGGGGACGCGAACCGCGTACCCCCGAGGAAGAGATCCTGTGCGGACTCTTCACCGAGGTCCTCGGACTGAAGCAGGTCGGCGCCGAGGACGACTTCTTCGACCTGGGCGGACACTCGCTGCTGGGTACCCGCCTGATCAGCGGGATCCGGGCGAAGCTCGGCTTCGAGGTGCGGCTGCTGACCCTGTTCGAGGCGTCCACGCCGGCCGCGCTGGCCCGGGCGATGCTGGAGGCGAACGCCCCGGCCCGGACAGCGCTGGAGCCGATGCCGCGACCGGAGCTCCTGCCGCTGTCGTTCGCCCAGCAGCGCCTGTGGTTCCTGCACAAGCTGGAAGGACCGTCGCCGACCTACAACATGCCGCTCACGCTGCAGCTCTCAGGGCCGCTCGACGTACCGGCGCTCCGCGCCGCGCTGACCGACGTGGTGGGCCGGCACGAGGCCTTGCGCACCGTCTTCGCCGAGCACGACGGCCAGGCGTACCAGCGGATCCTGGACCCGGTCGAGATCGAATTGCCGGTGCACGACGCCGCCTCGGACGAAGCGCTGCAGGCCGCCGCGCGCCATCGGTTCGACCTGGCCGGGGAAATCCCGCTGCGGGTGTCGCTGTACGCGGCCGGGCCGGGCGAGTGGGTGCTGATGCTGGTACTGCACCACATCGTCGCCGACGGGTGGTCGCTGCGGCCGCTGGCGCGGGACCTGGCGACGGCGTATGCGGCGCGCACGGCCGGCCGGGCCCCGGACTGGGCGCCGCCGCCAGTGCAGTACGCCGACTACACCCTGTGGCACCGGGAGTTGCTCGGCGACGACGCGGATCCGGACAGCGCGTTCGGCCGCCAGCTCGCGTTCTGGCGGGACCGGCTCGCCGACCTGCCCGAGCAGGTGACCCTGCCGACCGACCGCCCGCGGCCGAGGGTGGCCAGCTACCGGGGCGACGTGAGCACCTTCCAGGTGGACGCGGAGCTGCACGCGGGGCTGATGGCGCTGGCCCGGCAGACCGGTTCGACGCTGTTCATGGTGCTGCAGACCGCGCTGTCGGCGCTGCTGACCCGCTCCGGTGCCGGCACCGACGTGGTGGTCGGCGCCGGCGTGGCCGGTCGCACCGACGAACGCCTCGACGACCTCGTCGGCTTCTTCGTCAACATGGTGGTGCTGCGCACCGACACGTCCGACGATCCGACGTTCGTCGAGCTCCTTCAGCGGGTACGCGCCAGCAGCCTCGCCGCCTACGCGCATCAGGACATCCCGTTCGAGTACCTGGTCGAGAAGATCAATCCGCTGCGGTCGGCGTCGCATCAGTCGCTGTTCCAGATCGCCATGGTGCTGCAGAACAACGCCGAGGCCGACTTCGACCTCTCCGGCGTGCGGGTGTGGCAGGAGGGCCGTGGCACCGGCACGTCCCGGTTCGACCTGTCGCTGAGCCTGACCGAGACCACCACGGCCGACGGGCGCCCCACAGGTGTCACCGGCGTCGTCGAGTTCTCTACTGATCTGTATGACCGGGCGACGGTCGAGGCGTTCGCGGCTCGGTGGGTGCGGGTGTTGCGGGCGATGGTGGTGGCGCCGGGGTCGCGGTTGAGTGGGGTGCAGCTGCTGGGTGCCGATGAGCGGGTTCGGTTGTTGCAGCGGTGGGGGGCGGCGTCGGGTCCGGTGGCGGCGGTGACGCTGGCGGAGTTGTTCGAGCGTCGGGTGGCGGCCAGGCCGGATGCGGTGGCGGTTGTCGAGGGGGAGGTGAGCTGGTCTTATGCGCGGCTGAATGCGTACGCGAACCGGGTTGCCTGGTCGTTGGTCGAGCGCGGAGTGGGTGTCGAGGATGTGGTGGCGGTGGTGCTGCCGCGCGGCGCGGTGCAGGTTGCGACGGTGTTGGGTGTCGTCAAGGCGGGTGCGGCGTATCTGCCGGTGGATCCGAGTTATCCGCGGGCTCGGGTGGAGTATTTGTTGCAGGACGCCGGTCCGGCGTTGGTGATCGGTGAGTCGGATGTCTTCGACGGGCAGCCGGAGCACGATCCGGTGCGTCCGGTGCCGGTGGACGCCGCGGCGTATGTGATCTACACGTCGGGTTCGACGGGGCAGCCCAAGGGTGTCGTGGTGACCCACCGCGGGCTCAGCGGCCTCGCCGCCACCCTACGTCAGCGCTGCGCGGCCGACGTGGACAGCCGGATCCTGCAGGCTTCGTCGCCGAGCTTCGACGCCGCTGTGCTGGAGCTGGTCTGGGCCTGGGATTCCGGCGCCGCCCTGGTGATCGCCTCGGCGGATCGGCTGGCCGGGGACGAGCTGGCGCGTGCGCTCGCCGACCACCGGATCACCCACGCGCTGATCCCGCCGTCGGTGCTGAGCACCCTGGCGGCCGACGCGCCGCGGACGCTGACCGACTTCCGTACCCTCATCGTTGGTGCCGAGGCATGCCCGCCGGAGCTGCTGCGAAGGTGGGCGCCCGGCCGGCGGATGGTGAACGCGTACGGGCCGACCGAGGCGACCGTCGTCGCCAGCCAGACCGGTGAGCTGCACGAACCCCCGGTGTCGATCGGCAAACCGGCGCTCGGCACCCGGCTGTACGTGCTGGACGAGAGGCTCGGGCTGGCCGCTCCCGGAGTCCCGGGCGAGCTGTACATCGCCGGTGCCGGGGTGGCCCGCGGCTACCGCACGCGCCCGAGCCTGACGGCTTCCCGGTTCCTTGCGGATCCGTACGGCCCAGCCGGCACGCGGATGTACCGCACCGGCGACCTGGTCCGCTGGAACGCCGACGGGGACCTGGAGTACCTCGGCCGCTCCGACGAGCAGGTGAAGATCCGCGGCTTCCGGGTGGAGCCGGGCGAGGTGGAACGCGTCCTCGCCGCGCAACCGTCGGTGGCGCGGGCCGTCGTGGTGCCGCGGCCGGACCGCTCCGGCGCCGTCTCGCTCGCTGCGTATGTCGTGCTGGCGGACCAGGGGTCGGCAACCGACTTCGACGACCAGCTGGACGAGTGGCGCAGCATCTACCACGAGGTTTACAGCGGCCTGGCGCGCGAGCCGGGCACCGACTTCGCGGGCTGGAACAGTTCGTTCACCGGCACGCCGATCCCGATCGAGCAGATGCGGGAGTGGCAGCGGTCCGCGGTGGAGCAGGTGGCCCGGTTCGGCCCTCGCCGGGTCCTGGAGATCGGCGCGGGCTCCGGCCTCCTGATGGTCCCGCTGATCGAGCGGACCGAGGAGTACTGGGCGACAGACTTCTCGGCGGCCGCCGTCGAGCGGCTGCGGGAGTACGCCCGGGAACGCGGCTGGGAGCACGCGCACCTGCGATGCCAGCCGGCCCACGACATGTGGGGGCTGCCCCGCAGCCACTTCGACACCATCGTGCTGAACTCGGTGGTCCAGTACTTCCCGAGCACGGATTACCTGCGCGACGTGCTGGGCAAAGCGCTCGACCTGCTGGCCGACGGTGGCCGGCTTGTCGTCGGCGACGTGCGGCACCACGGCCTGCTGCGGGCGATGCACACTGCGGTACAGGAGTTCCGCAACCCCGGGTCCGGCTCGTCGGCCGTGGACCACGCAGTGGCGATCGAAAAGGAACTGCTGCTCGCGCCCGAGTTCTTCACCGCCTTCCGGCATCCGCGGGCCACCGGCGTCGAGGTGTTGCTCAAACGGGGCAGCGCGGACAACGAGCTGACCGCTTACCGGTACGAGGTGGTGCTGCACACCGGCGCCACCCGGCCGGTCGGGGACCTGCCGGAGCTGGTCTGGGGCCATGACGTGACGGACCTGGCCGACGTGACGGCGCCGGCACGTCTGACCCGGATACCGAACCCGCGACTGGTCGGCATCAACGAACCCCGGCTGCACCCGGAGCAGGTACGCCGGTGGGCCGCGGAGCGCAGCTGGCGGGCGGTGCCCACCTGGTCGCCGCGGAACTGGGACGGGTACGACGTGGTGCTGCTCGCCGCCGACGAGGACGAGGCGCTCACAGACGTCTACCGGCCGGGCACTCCGGAGGTGGTCGCCAACGTGCCCGCGGTCGCCCGCACCGCCGGTGAGCACGTCTCCGAGCTGCGCGGCACGATCAAGTCGTTGCTGCCCGACCACATGGTGCCGGCCACGATCACGCCGATCGAGCGGATCCCGCTCACCCCGAACGGCAAGATCGACCGCCGGGCGCTGCCGGAACCCGAGATCGTCACCACCACGACCGAGGAGCGCGGGCCGCGCGACCCGTACGAGGAGATCCTCTGCGAGCTGTACGCCGACCTGCTCGGCCTGCCCCGCGTCGGGGTCGACGAGAGCTTCTTCGACCTGGGCGGGCACTCGCTGCTGGCCACCAGGTTGACCAGCCGGATCCGTGCCGTGCTCGGCATCGAGGTGCCGCTGCAGCAGGTGTTCGCTGCGTCAACGCCAGCCCAGCTTGCCGCAGTGCTGGCACAGGGGTCGGGCCGTGCGGGGCCCGCACTGGAGCCGGCGCCACGGCCGGAGGTCCTCCCGTTGTCGTTCGCACAGCAGCGCCTCTGGTTCATGCAGAACCTGGAGGGGGCGTCGGCGACGTACAACTCGCCGCTGGCGGTGCGTTTGTCCGGCGCGCTCGACGTGGCCGCGATGCGTGCCGCCCTCGGCGACGTGCTGGCCCGGCACGAGGTGCTGCGCACCGTCTTCGGCGAGCGGCGCGGGGAGCCTTACCAGCGGATCCTGGATGCCGTCGAGATCGACCTGCCGGTACGTGCGGTGGCCGAGGGCGACTTGACCCAGGTGCTCCGGGACGCCTCCCGGCACGAGTTCGACCTGTCCCGGGAGATCCCGGTGCGGGCGTCGCTGTTCAACACCGGCCGCGACGAATGGGTGCTGCTGCTGGTCGTGCACCACGTCGCGGTGGACGGCTGGTCGATGCGGCCGCTGACCCGGGACCTGACCACGGCGTACGAGCAACGCGCGGCCGGTCGCGTCCCGGACTGGGCGCCGCTGCGGGTGCAGTACGCCGACTTCGCCCTCTGGCAACACCGGATGCTGGGCGACGAGGCCGACCCGGACAGCCGGCTCAGCCGCCAGCTCGCCTACTGGCGTGACCAGCTGGCCGGTCTGCCGCGACTGGTGACGTTGCCGGCCGATCGGCCCCGCCCGGACGAGGCCAGTCATCGGGGCGCCATGCTGACTCGCAACCTCGACGCGGACCTGCACCAGGCTCTGCGCGTGCTGGCCCGGCGCCACGGATCCACCCTGTTCATGGCGTTGCAGGCGGCGCTCGGCGCGCAGCTGAGCCGCAGCGGGGCCGGTACCGACATCCCGGTCGGCGCGCCGATCGCGGGACGCGCCGACGACGCCCTCGAGGACCTGGTCGGCTTCTTCATCAACACGCTCGTGCTGCGGATCGACACCTCCGGCCGCCCCAGCTTCACCCGGCTGCTGAAGCAGGTGCGGGAGACCAGCCTGGCCGCGTACGCCCATCAGGACGTGCCCTTCGACCACCTGGTAGAGAAGCTCAACCCTGACCGGTCGCCCGGGCAGCACCCGCTCTTCCAGGTGCAGCTGGTGCTGCAGAACACGCCGGACGCCGAGTTCGAGCTGGCCGGGCTGACCGCACGGCCGCAGCTCGACGGGGTCGAGACCGGGGTGTCGCGGGTGGACCTGTCCGTCAACGCGATCGAGACGTTCGACGACCACGGCCTGCCCGCCGGGCTGATCCTCGTCGTCGAGTACGCCACCGACCTCTACGACAGTGCGACGGTCGACGCCTTTCTCGACGAGTTCGGCCAGCTGCTGCACGAAGTCGCCGACTCGCCCGACCAACCCATCGGAGGACTCGAATTGGACAACATCGCCGCGCCGGTGCCGGGAACTCTGCCGCAGCTCTTCGAAACCTGGGCTGCCGCCACGCCGTCCGCGATCGCCGTGACCGACGGCGCGGCCGACATGACGTACGCCGAGCTGAACAGCCGCGCCAATCGGATGGCGCGGGCGCTGATTGACCGCGGGGCCGGCCCGGAGGACCTCGTCGCCGTGCTGCTGCCGCGCAGCGTCCGGCAGGTCGCCACGATTCTGGCCATCGCCAAGAGCGGAGCGGCGTACCTACCGATCGACCCGACCTACCCGGCTGACCGGGTGGCGTATCTCTGCGCGGACGCCCTGCCGAAGCTGATCGTGACGGACGCCGCCGGGTCGGCCCGCCTCGGCGCCGACCAGCCGGTGATCGACGTTGACGACCCGGCCACCGTGGCGCAGTGGGAGAGCCGGCCGGACACCGACCCGACCGACCGCGACCGCACGACCGCCCTCGGCCTCGACCACCCGGCCTACGTCATCTACACGTCCGGTTCGACCGGCCGGCCCAAGGGTGCGGTGATCACCCAGGCCGGTCTGGCGGGCGCGGCCGAAGCCTGGGTGCAGCGCTGGGGGTTCGAGCCGGGCAGCCGGGTCCTGCAGCTCTCCTCGCCGAGCTTCGACGCCTCGATCATGGATTTCATCGTGGCGTTTGCCGCGCAGGGAACGCTCGTCCTGCCCGAGCCGGGACTGATCGCGGGTGAGGCGCTGGCCCGGGTCCTGACCGAGAAGCGGATCACGCACCTGGTGACCCTGCCGTCGGTGCTGGCCAGCATGCCGGTCGACGTGGCGGGCCGGCTCACCGGCCTGCGCGGCCTGCTGCTCGGCGGCGAGGTGTTGACACCCGATCTCGCCGCGCGCTGGTCGCCGGGCCGACGTATGATCAATGTTTACGGCCAGACCGAGACCACCGTCGCCTGCACGATGACCGACCCCCTGGCCGGCGAACGCGTCACGGTCGGCCGGCCGATCCCGGGGACGCGGGTGTACGTCCTCGACGCGCTCCTGCGAGTCGTGCCGCCTGGCACCGACGGCGAGCTGTACGTGGCCGGTCCCGCGGTCGGGCGCGGATATCTGCACCGGGCCGGACTGACTGCGAGCCGGTTCGTCGCCGACCCGTACGGCCCGCCCGGCTCACGGATGTACCGCACCGGTGACCTCGGCCGTCTCAACTACGCGTTCGAGCTGGAATATGCCGGCCGTACCGACGAGCAGGTGAAGATCCGCGGGATGCGGGTCGAGCCGGGCGAGGTGGAGGCCGCGCTGGCCGAGCATCCGGCGGTGGCGCGGGCCGCGGTGGCCGTACGGGCCGACCGCCAGGGCGACCTGGCCCTGTTCGGGTACGTCATCCCGGTCCAGGCCGGCGCCGACGTCAGCGGTATCCGCGAGGACCTGCGCCGGTCGCTGCCCGAGCACCTGGTGCCGGCGGTGATGACGGCGATGACGGACTTCCCGCTCACGCCGAACGGCAAGGTGGACCGGGACGCGCTGCCGGCCCCGCAGGTCACGGCGCCGGTCGGCCGTGGGCCGCGTACGCCGCAGGAGGAGATCCTCTGTGGCCTGTTCGCCGAGTTGCTGGGCCTGGGCCAGATCGGCGTCGAGGACAACTTCTTCGATCTCGGCGGCCACTCGCTGCTGGCGAACAAGCTCATCGCCCGGATCGCCGAGGTGATGGGCACGGAGATCCCGATCCGGACGTTCTTCGCCGGGCCCACCGTCGCGCAGCTCGCCGAGCAGCTCGGCTCTGACGGCACCGACCGGGCCTTCGACGTTCTTCTGCCGCTGCGTACCGGGGGCACCCTGCCGCCGCTGTTCTGCATCCACCCGGGTGCCGCGATCTGCTGGTCCTACGCGGATCTGCTGCTGCACCTGAGCCCGGACTTCCCGGTGTACGGGCTCCAATCGCCCGCGCTGAGCCACCCGGACGAGCTCCCGGAAACCCTGATCCAGGTGGCCGACGACTGCATTGAGGAGATGCGTCAGGTGCAGAAGACCGGCCCGTACTACCTGCTCGGGCAGTCGTTCGGCGGGGTCGTGGCGCACGCCATGGCGGCTCGTCTGGAGGCCGCCGGAGAACAGGTCGGGCTTATCGTGGCGCTCGATTCGGAGCCGTCGCGGTCGTTGAGCGAGCACGAGCAGGCGCAGGTCATCGAGGCCACCGCCAAGGTCTACACCGGCATCCTCGAGGTACTGGGGGTCGACCCGGCGGCCCTGCCGAGCGGGAACCTCACCTTCGCACAGTTCTCCGAACTGGCCCGGACCACCAACACGTTGCTGGGCAACGTCGCCGAAGACGAGTTCCACCTGCTCATGGCGATTCTGCACGGCAACATCTCGATCGCCACCAGGCACCGTTCGGAACGGGTTGACGCCGACATGTTGATCTTCGGCGCGGCCGAGGAACGGGAACGGGTGCTCGACCCCGAGGTCTGGCGGGAGTTCGTCGGCGGCGAGATCACCTACCACCCGATCCCGACCAGTCACAGCACGATCATGGCGCCGGAGGCGCTCCAGGTGATCGGTCCGATTCTCGAGCAGCACCTGCGGGCCGTCATCGCCGGCAACGCCACAACCAAGGAGGAGAACTGA	MEVSMSSADVAATIVRLYESAVEAHPDKPVINDGHRVWSYRELNSAANRIAWWLIGRGVGPEQTVGVALDRGIDQIAALLGTLKAGAVYLPLDPVLPAERINYLLADATPSLILDGDAAASAGQPEDTPAVPLTSDSLAYVIYTSGSTGTPKGVGVTHGSMVNLARTVTGQYALGDTPRVLQLASLGFDVAIWELLTAVATGGTLVVSQADQLSGDDLLRVLREQRITHVTLPVPVLASLPPDAENQLPDLTTVHIGGETCPPELVRRWSAGRRLINGYGATETTVAATLTPPLTGPDAPIGKAIDGTRVYVLDDTLAQVVLGAAGELYVAGANVARGYLRRPGLTASRFLADPYGPPGSRMYRTGDVGLIRPDGQLEFLRRADDQVKIRGARVEPGELEAVLQRRTDVVHAAVTVRPDARGERQLVAYVVPAAAATGAAELRDDLRGTLPSYLVPSSVVLLDSLPLTPNGKVDRDALPDPEYAPAGLDRTARSPLEDMLRVVFAEILELPQVGFDDDFFDLGGHSLLAGRLIGRIRGTLGLEVHMKDFFEKSTPAALASYLQRQETGPARPELTRLPRPDRIPLSFAQQRLWFLHRLEGPSATYNMPLALHLTGKVDTGALAAALTDVIRRHEPLRTLIREVDGQPYQQILDPEEVRPALPVRQVGAAQLDEELRRSARHEFDLARQIPVRAELLTVSPDESVLMLVIHHIAGDGWSGAPLARDLVTAHSARLTGVAPQWPPLPVQYADYTLWQRAMLGGEEEPASPLNEQLRYWREQLADLPHEITVPGDRPRPAVATYRGGVVPITMDADLHAGITELARRNGATVYMVLQSTVTALLTRLGAGTDVAIGAGVAGRSEPALDDLVGLFVNMLVLRTDTAGSPRFTELLQQVRDTSLGAYGHQDIPFEQLVESLNPHRVAGRQSLFQVALVLQNNTSVPFDLPGLRVRAEQIPTGTARFDLSLSVTEHGDGISGTVEYAADLYDRATAEAVVERWIQLIRQVVADPARRVDTLDVTTPGDESRLAGWRRYERDVPPVTFGDLFARQVAATPDAIAVSDGGDVWTYREVNRYANHVADRLIDRGIGPEDFVAVAMPRSARLVASLLGVLKAGAAYVPVDLVFPARRNRHVIIDSNPRLVLTSRAGAENLPADLPCELVMIDAWGTGREDGPADADRVRPSNVDSPAYVIYTSGSTGQPKGVVVTHRGLAAFAETLRERCAAGPNDRVLQLSSPSVDASVLEMVWAFSSGARLVIASQYRLAGEELAQALAEQRITHAHIPPSALSTIPAEAAGRLPEFRRLSVGAESCPSELVRLWLPGRDFVNAYGPTECTVAASHTFPLAEARAPIGRPVIDAELYVLDETLRPAAPGVPGELYIGGAGLARGYLRRGGLTASRFVANPYGEPGSRVYRTGDVVRWNTDGELEYLGRSDEQVKVRGFRVEPGEVERVLASQPSVDRAVVVPRRDRSGAVSLAAYVVLAAASPAGFDDQLSEWNDIYDQVYAGFSGDAGNDFIGWTSSFTGGPIPIEEMREWQRSAVDAVRRFGRGRVLEIGSGSGLLMTPLADAVDEYWGTDLSEISIDRLRAFADARRWNHVRLSCQPAHDVSGLPRRYFDTVVINSVVQYFPSADYLRDVLAKVVDLLADGGRVIVGDVRHYGLLRVFHAAVHDFRGTEGLRAAVEHAMAVEKELLLAPEFFTSIDHPAVTGVEVTLKAGQASNELTGYRYEVVLHTAPARRLTTLPVLVWGRDTTDLDEVTGPARVTGIPNPRLAGGVAAVRLLDGMDAVPPAAGPELESEAVRRWAVQRGMRAVPTWSSNRWNTYDVVLIHAAEAEPLADVYRPADGVEPANVPEVARTAGKLVSELRSTVQGLLPDYMVPATITPIERIPVTPNGKIDRRALPDPEVVLSRGRHARTPLEQILCELYADILGLERVGVDDSFFDRGGHSLLATRLTSRIRSVLGVEALLQQVFAAPSPAELAVVLSEQQGRVQQALEPVARPEVLPLSFAQQRLWFLHKLEGPSATYNSPLALRLSGTLEVTALRAALGDVVGRHEALRTVFAETDGVPYQKVLDVADVDLSVREVAADELPGVLRDAARYEFDLAREIPVRAWLFAAGPGEWVLMLVLHHIAADGWSLGPLARDLATAYADRRMGRGPSWSPLPVQYADYTLWQRRLLGDEADPDSVFGRQLAYWRGQLAGLPQQVTLPTDRPRPQTASYAGDVTMFRLDAGLHADLLRLARTSGATLFMVLQAALVAVLTRLGAGDDVPLGSPIAGRSDDGLDDLVGFFVNTLVLRADTSGNPGFDELLERVRDTSLEAYAHQDVPFEFLVEKLNPHRSTAHSPLFQVLLAFQNNSDTSFHLPGLRAEREEIGTRVSRVDLTLNITEAFGVNGAPQGIRGAVEYATDLYDARTVESFAARFVRMLQAAVADPSRRINAVDLLSDEENATVLALSGRDAAVPESRVWPAVFEATAAAAPDATAVVEGQLSWTYAQLNANANRLARYLIDRGVGPEDVVGVLMPRSAMQIATVLAIGKAGAAFLPIDPAYPAERVEYLIADARPKMLLADTAHVGVAAGAIAIDEPAVATALREAPVTDPAGVAVRLEHPAYVIYTSGSTGRPKGTIVTHSGLAALAVSGCERAAVDRDSRVLQLTSPSFDVSVFEFLAAFHAGAVLVMPEPGRLAGEELAELLADAGVSHAFVPPSVLATLPDEAPGRLAGLRSLVVGGEACSADLVRRWSVGRRMTNLYGPTETTVAASISRPMSTGAHPIGAPLPGTRVYVLDANLRPVPPGARGELYISGIGVARGYLGRPVLTASRFVADPFGPAGARAYRTGDVVRWNADGELEYFGRSDHQLKIRGFRVEPGEIEAALVRRPSVAQAVVVARPDQHGFQALYAYVTAGAEPADAARLREELRAELPDYLVPAAIVVLDEFPLNANGKLDRNALPEPRFVTSAADIRSPGMPQEEILRSVFADVLGIERISADDNFFDLGGHSLLVTRLISRVRGTLGVDVSMQTFFNAPTPRQLAGQLLEGGPVPARLQPVPRPEALPLSFAQQRLWFLHKLEGPSATYNSPLAIKLSGELDVDALRLALADVVVRHEALRTVFAERAGNPYQRILDSAEVELPVREVPQSKLPDALREAARYEFDLAREIPLRAWLFTAGPGEWVLMLALHHVVADGWSLQVLVSNLTAAYTSRRAGHAPSWQPLPVQYADYTLWQRRHLGTEDDPDSVSSRQVSYWLEQLADLPDQVTLPTDRPRPAVASYRGETVTFDLDAEEHAELVRLARETGTTLFMILQAALAGLLTRLGAGTDIAIGSPIAGRTDDRLENLIGLFVNMLVLRTDTGGDPTLGELLTRVRETSLAAYAHQHMPFEYLVERLNPHRSAAHHPLVQILFGLQNTAEQNVSLPGVTASGMSVDTGVSRVDLSINIVEASAPDGSPAGLTGLVEFSTDLYDRATVEAFAARWVRVLRAMVVAPGSRLSGVQLLGADERVRLLQRWGAASGPVAAVTLAELFERRVAARPDAVAVVEGEVSWSYARLNAYANRVAWSLVERGVGVEDVVAVVLPRGAVQVATVLGVVKAGAAYLPVDPSYPRARVEYLLQDAGPALVIGESDVFDGQPEHDPVRPVPVDAAAYVIYTSGSTGQPKGVVVTHRGLASMAATQQRLGAGEGSRVLQFAALGFDATVWELVMALGAGAALVVPKTDQLAGEDLAAVLREQRITHLTLPPTVLATVPADRLPDLGTLVVAGEACPPELTARWSPGRRMFNAYGPTESTVCASISAELSPGLAPIGGPVLNTRLYVLDDALQPAASGVPGELYIAGEGLARGYRGRAGLTATRILADPYGPVGSRMYRTGDVVRWNADGDLEYLGRSDEQVKIRGFRVEPGEVASVLLRHPAVAQAAVIVRLEQLLAYAVPALGRAVRDGELRAYLQDELPEHTVPSAVVLLDEIPRTSHGKVDQRALPDPEQAGGRGRAPRTPQEELLCVLFAQVLDVQQVGPDDSFFDLGGHSLLATRLIIRIRRAFRCELPPRALFAAPSPAELAVVLSEQQGRVQQALEPVARPEVLPLSFAQQRLWFLHKLEGPSATYNSPLALRLSGTLEVTALRAALGDVVGRHEALRTVFAETDGVPYQKVLDVADVDLSVREVAADELPGVLRDAARYEFDLAREIPVRAWLFAAGPGEWVLMLVLHHIAADGWSLGPLARDLATAYADRRMGRGPSWSPLPVQYADYTLWQRRLLGDEADPDSVFGRQLAYWRGQLAGLPQQVTLPTDRPRPQTASYAGDVTMFRLDAGLHADLLRLARTSGATLFMVLQAALVAVLTRLGAGDDVPLGSPIAGRSDDGLDDLVGFFVNTLVLRADTSGNPGFDELLERVRDTSLEAYAHQDVPFEFLVEKLNPHRSTAHSPLFQVLLAFQNNSDTSFHLPGLRTRLEGVSTGLSRVDLFISLAEQPDAGGVIGAVEYATDLYDAATVEAFVGRWLRFLAAVAHDPEQRIGSVDLLLDGERERLTGWAYTEPEVEPATLSELFERRVAARPDAVAVVEGEVSWSYARLNAYANRVAWSLVERGVGVEDVVAVVLPRGAVQVATVLGVVKAGAAYLPVDPSYPRARVEYLLQDAGPALVIGESDVFDGQPEHDPVRPVPVDAAAYVIYTSGSTGQPKGVVVTHRGLAALATGTVGRNAVAGDSRVLLLASPSFDASVLELMIAIGAGAALVVSRESRLAGEELATLIAQARVTHAFVPPSVLATLPGAATGELPAFQGLVVGGEACSPDLVRRWSAGRRMTNLYGPTETTVATTVSRPLFGEAHPIGAPLPGWRVYVLDAGLHLVPPGSRGELYIGGVGLTRGYLRRAGLTASRFVADPFGPAGARMYRTGDVVRWNADGELEYLGRSDHQVQIRGIRVEPGEVQAALTAHPDVARAVVVVSDDRRGDPALVGYMVPERPGADPAAVREDLRRILPDHLVPVAIVVLPEIPLTPNGKLDRDALPDPEYETSRGREPRTPEEEILCGLFTEVLGLKQVGAEDDFFDLGGHSLLGTRLISGIRAKLGFEVRLLTLFEASTPAALARAMLEANAPARTALEPMPRPELLPLSFAQQRLWFLHKLEGPSPTYNMPLTLQLSGPLDVPALRAALTDVVGRHEALRTVFAEHDGQAYQRILDPVEIELPVHDAASDEALQAAARHRFDLAGEIPLRVSLYAAGPGEWVLMLVLHHIVADGWSLRPLARDLATAYAARTAGRAPDWAPPPVQYADYTLWHRELLGDDADPDSAFGRQLAFWRDRLADLPEQVTLPTDRPRPRVASYRGDVSTFQVDAELHAGLMALARQTGSTLFMVLQTALSALLTRSGAGTDVVVGAGVAGRTDERLDDLVGFFVNMVVLRTDTSDDPTFVELLQRVRASSLAAYAHQDIPFEYLVEKINPLRSASHQSLFQIAMVLQNNAEADFDLSGVRVWQEGRGTGTSRFDLSLSLTETTTADGRPTGVTGVVEFSTDLYDRATVEAFAARWVRVLRAMVVAPGSRLSGVQLLGADERVRLLQRWGAASGPVAAVTLAELFERRVAARPDAVAVVEGEVSWSYARLNAYANRVAWSLVERGVGVEDVVAVVLPRGAVQVATVLGVVKAGAAYLPVDPSYPRARVEYLLQDAGPALVIGESDVFDGQPEHDPVRPVPVDAAAYVIYTSGSTGQPKGVVVTHRGLSGLAATLRQRCAADVDSRILQASSPSFDAAVLELVWAWDSGAALVIASADRLAGDELARALADHRITHALIPPSVLSTLAADAPRTLTDFRTLIVGAEACPPELLRRWAPGRRMVNAYGPTEATVVASQTGELHEPPVSIGKPALGTRLYVLDERLGLAAPGVPGELYIAGAGVARGYRTRPSLTASRFLADPYGPAGTRMYRTGDLVRWNADGDLEYLGRSDEQVKIRGFRVEPGEVERVLAAQPSVARAVVVPRPDRSGAVSLAAYVVLADQGSATDFDDQLDEWRSIYHEVYSGLAREPGTDFAGWNSSFTGTPIPIEQMREWQRSAVEQVARFGPRRVLEIGAGSGLLMVPLIERTEEYWATDFSAAAVERLREYARERGWEHAHLRCQPAHDMWGLPRSHFDTIVLNSVVQYFPSTDYLRDVLGKALDLLADGGRLVVGDVRHHGLLRAMHTAVQEFRNPGSGSSAVDHAVAIEKELLLAPEFFTAFRHPRATGVEVLLKRGSADNELTAYRYEVVLHTGATRPVGDLPELVWGHDVTDLADVTAPARLTRIPNPRLVGINEPRLHPEQVRRWAAERSWRAVPTWSPRNWDGYDVVLLAADEDEALTDVYRPGTPEVVANVPAVARTAGEHVSELRGTIKSLLPDHMVPATITPIERIPLTPNGKIDRRALPEPEIVTTTTEERGPRDPYEEILCELYADLLGLPRVGVDESFFDLGGHSLLATRLTSRIRAVLGIEVPLQQVFAASTPAQLAAVLAQGSGRAGPALEPAPRPEVLPLSFAQQRLWFMQNLEGASATYNSPLAVRLSGALDVAAMRAALGDVLARHEVLRTVFGERRGEPYQRILDAVEIDLPVRAVAEGDLTQVLRDASRHEFDLSREIPVRASLFNTGRDEWVLLLVVHHVAVDGWSMRPLTRDLTTAYEQRAAGRVPDWAPLRVQYADFALWQHRMLGDEADPDSRLSRQLAYWRDQLAGLPRLVTLPADRPRPDEASHRGAMLTRNLDADLHQALRVLARRHGSTLFMALQAALGAQLSRSGAGTDIPVGAPIAGRADDALEDLVGFFINTLVLRIDTSGRPSFTRLLKQVRETSLAAYAHQDVPFDHLVEKLNPDRSPGQHPLFQVQLVLQNTPDAEFELAGLTARPQLDGVETGVSRVDLSVNAIETFDDHGLPAGLILVVEYATDLYDSATVDAFLDEFGQLLHEVADSPDQPIGGLELDNIAAPVPGTLPQLFETWAAATPSAIAVTDGAADMTYAELNSRANRMARALIDRGAGPEDLVAVLLPRSVRQVATILAIAKSGAAYLPIDPTYPADRVAYLCADALPKLIVTDAAGSARLGADQPVIDVDDPATVAQWESRPDTDPTDRDRTTALGLDHPAYVIYTSGSTGRPKGAVITQAGLAGAAEAWVQRWGFEPGSRVLQLSSPSFDASIMDFIVAFAAQGTLVLPEPGLIAGEALARVLTEKRITHLVTLPSVLASMPVDVAGRLTGLRGLLLGGEVLTPDLAARWSPGRRMINVYGQTETTVACTMTDPLAGERVTVGRPIPGTRVYVLDALLRVVPPGTDGELYVAGPAVGRGYLHRAGLTASRFVADPYGPPGSRMYRTGDLGRLNYAFELEYAGRTDEQVKIRGMRVEPGEVEAALAEHPAVARAAVAVRADRQGDLALFGYVIPVQAGADVSGIREDLRRSLPEHLVPAVMTAMTDFPLTPNGKVDRDALPAPQVTAPVGRGPRTPQEEILCGLFAELLGLGQIGVEDNFFDLGGHSLLANKLIARIAEVMGTEIPIRTFFAGPTVAQLAEQLGSDGTDRAFDVLLPLRTGGTLPPLFCIHPGAAICWSYADLLLHLSPDFPVYGLQSPALSHPDELPETLIQVADDCIEEMRQVQKTGPYYLLGQSFGGVVAHAMAARLEAAGEQVGLIVALDSEPSRSLSEHEQAQVIEATAKVYTGILEVLGVDPAALPSGNLTFAQFSELARTTNTLLGNVAEDEFHLLMAILHGNISIATRHRSERVDADMLIFGAAEERERVLDPEVWREFVGGEITYHPIPTSHSTIMAPEALQVIGPILEQHLRAVIAGNATTKEEN	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	1400.90	gnl|BL_ORD_ID|4935|hsp_num:0	5928			111	1635	colistin A; colistin B
BGC0000333.1|Cyclomarin_18 # 41780 # 41995 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.653	BGC0000333.1|Cyclomarin_18 	41780	41995	+	Loose	600	23.8682	CepA-49	40.0	3006226	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CepA beta-lactamase	ATGGGTAACCCGTTCGACGACACCGAGGGCCGGTTCCTGGTGCTGGTCAACGACGAAGGTCAGTACTCGATGTGGCCGGCGGTGATCGACGTGCCGGCAGGGTGGACCGTCGTCCACCCCGAGGACAGCCATCAGGCATGCCTCGACTACGTCGAGCAGAACTGGACCGACATGCGCCCGCGGAGCCTTGTCCGCGCCATGGGTGAGGAGTCCTGA	MGNPFDDTEGRFLVLVNDEGQYSMWPAVIDVPAGWTVVHPEDSHQACLDYVEQNWTDMRPRSLVRAMGEES	MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDIHYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIADLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNWTTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGDRNAKGQQIGCNDIGFILLPDGHVYSIAVFVKDSEADNRENSEIIAEISHIVYEYVTQQID	23.67	gnl|BL_ORD_ID|3375|hsp_num:0	4444			483	543	
BGC0000333.1|Cyclomarin_20 # 42633 # 43754 # 1 # ID=1_20;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.700	BGC0000333.1|Cyclomarin_20 	42633	43754	+	Loose	2000	26.1794	Staphylococcus aureus mupA conferring resistance to mupirocin	47.06	3000521	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	TTGACCGAGGAGTTGACGACGGTCCGAGACGCCTGCGCCAGAACGTTGGAGAACACGGCACGGACACTGCACCTGGGAGCCAGCGGTACGGAATTCGTCGCGGCGTTCCGGGCCATGACCGACCACTGGGGCGCCGCCCGCCCCCACGATCTACCCCTGTCGGACGTGTCACCCGACGGGTCGCCGGTGGAGTACGCCGTCGACCTCGGCGGGCTCGCGCCCGCACTCCAGTTCGCCATGGAGCCGCTGACCGCGGGCGTGCCGGCTCGTGATCCCCTCGCGGCGCGGGCCATCATGCCGCTGCTGGCCGGGCGGTACGGCGCCGACGCGACCCGGTGGTCGGCCCTCGCGGACCGGCTCCTGCCAGACGACGCGCACGGCCCGCACGTCTCCATGTACGGCGCCGAGGTTCGGGCGGGTGCCCCGATCCGGTTCAAGGCCTGGTTCTACCTGAACGTGACCGGCCCGGACGGCGCCTTCAACCTGCTGTACTCCGCCTTGGAACGGATGGGTACGACGCACCTGTGGCCGGTCGTCCAAGCGCACGTGCACCGCGCTGGGGAGGACGTGCCGTTCCTGCTGTCGCTGGACCTGTCGGACGACCCGGCGGCCCGGGTGAAGGTGTACTTCCGGCACTTCGCGGCGGATGTCGAGGAGGTCGCGGCCGTGCTCAAGGCGTACCCAGGTTTCGAGCCGGGCGAGGTGCGGGCCTTCTGCAAGGTCATGATGGGCGGTCGGCGCCGCTTCAGCGACCAGCCGGCCGTCACCTGCGTATCACTGCTCGACGCGCAGACCTTCGATCGCACTGCGGCCACCCTCTACGTTCCGCTGTGGACGTACGCCGAGCACGACGGCGAAGTGCGGCAGCGGGTGCACCGGACCCTGGCTGCGTGGCCGGAGGCGCTGTACCGCTACGACAGCGTGCTCGCCGGCATCGCGCACCGCGGGCTGGACGCCGGAACCGGGATCCACAACTACATCTCCTGGCAACCCGGCCGGACCCGCCCGCGGATGAAGGTCTACCTGTCACCGGAGATGCACGACGTCACTCCTCCGCCGCTCGGCGTAAGCCAACAGCATCACCTCAGTGGCCAGACCACTGCGAGAGGGAGAACCGAATGA	MTEELTTVRDACARTLENTARTLHLGASGTEFVAAFRAMTDHWGAARPHDLPLSDVSPDGSPVEYAVDLGGLAPALQFAMEPLTAGVPARDPLAARAIMPLLAGRYGADATRWSALADRLLPDDAHGPHVSMYGAEVRAGAPIRFKAWFYLNVTGPDGAFNLLYSALERMGTTHLWPVVQAHVHRAGEDVPFLLSLDLSDDPAARVKVYFRHFAADVEEVAAVLKAYPGFEPGEVRAFCKVMMGGRRRFSDQPAVTCVSLLDAQTFDRTAATLYVPLWTYAEHDGEVRQRVHRTLAAWPEALYRYDSVLAGIAHRGLDAGTGIHNYISWQPGRTRPRMKVYLSPEMHDVTPPPLGVSQQHHLSGQTTARGRTE	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	36.43	gnl|BL_ORD_ID|4699|hsp_num:0	2270			1794	1845	mupirocin
BGC0000333.1|Cyclomarin_21 # 43751 # 44638 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.688	BGC0000333.1|Cyclomarin_21 	43751	44638	+	Loose	400	26.5646	IND-4	29.73	3002260	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGAGTACGCAGACGCATCCAGCTCCGCTGCGGACCGCCATCGTGGGGACCGGGAACATCGGAACCGATCTGCTCCTGAAGGTCGAGGCGTCCCCGCTGCTGACGTGCGTCCTGTTCGCCGGGCGGCGGGCCGAGTCGCCCGGCATCGAGCTGGCCCGCGGTCGCGGAGTGGCCACCAGCACCGGCGGTATCGACGCCGTGGTCGATGCGGCTGACGACATCGATCTGGTCTTCGACGCCACCTCGGCCAGGGACGCCGTCCGGCACTGGGCCGTCATCAAGCCGCTGGGGCTGCCGTTCATCGACCTCACACCGGCTAACCAGGGCAAGTTCTGCGTCCCGGCGCTCAACCTGGAGGACTGCCTCGATGAGCAGTACCTCAGCATGGTGACCTGCGGCGGGCAGGCGGCGGTGCCGATGGCTCGGTGCATCACGCAGATCGCCGGCCACGTCGACTACCTCGAGATCGTCTCGGCGAGCGCCTCGGCCAGCGTCGGTCCGGCCTCGCGCGCGAACCTCGACGAGTACGTGCACACCACGGAACAGGCCACCGCCGAGTTCTGCAGCACCGCGCGCACCAAGACCGTGCTGATCATCAACCCGGCTGATCCGGGCATCGTGATGCGCAACTCCATCGCGGTCTCCACCACCGAGCGGATCGACATCGACGCCCTGCGCGACTCGGTCACCGCCATGGAGAAGGAGATCCACTCGTACGTTCCCGGGTACCGGATCGTGGTGCCGCCGGTCGCCACCGGTGACTGCTACCTGCTCACCGTCGAGGTCGAGGGGCTGGGCGACTACTTCCCCCGCTCCGCCGGGAACCTGGACATCATCACCTGCGCCGCCGTCGCCGCGGCGGAGGCTCGCAGCGGGCTGAGGCGTTGA	MSTQTHPAPLRTAIVGTGNIGTDLLLKVEASPLLTCVLFAGRRAESPGIELARGRGVATSTGGIDAVVDAADDIDLVFDATSARDAVRHWAVIKPLGLPFIDLTPANQGKFCVPALNLEDCLDEQYLSMVTCGGQAAVPMARCITQIAGHVDYLEIVSASASASVGPASRANLDEYVHTTEQATAEFCSTARTKTVLIINPADPGIVMRNSIAVSTTERIDIDALRDSVTAMEKEIHSYVPGYRIVVPPVATGDCYLLTVEVEGLGDYFPRSAGNLDIITCAAVAAAEARSGLRR	MRKNVRIFTVLSLFLINFFNAQARDFVIEQPFGKQLYLYKTFGVFDGKEYSTNALYLVTKKGVVLFDVPWQKTQYQSLMDTIKKRHNLPVIAVFATHSHSDRAGDLSFYNKKGIPTYATAKTNELLKKEGKATSSKLTKIGKKYKIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSSAAVDLGYTGEANVEQWPATMKKLQAKYPSTAKVIPGHDEWKGNDHVKHTLELLDQQKQ	121.90	gnl|BL_ORD_ID|1589|hsp_num:0	1734			537	648	
BGC0000333.1|Cyclomarin_22 # 44638 # 45684 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.695	BGC0000333.1|Cyclomarin_22 	44638	45684	+	Loose	700	25.409	oleD	39.02	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGCGTGAAACTGCAGATCTGTGACTCGACGTTGCGCGACGGCAACCACGCCGTCGCTCACCAGCTCGGCCGGGCGGACATCAGCGCGTACGCTCGGGCGGCCGAGGAGGCCGGGGTGGACGTCCTCGAGGTCGGGCACGGCAACGGGCTCGGCGCCTCGTCCATTCAGGTCGGCATTGCCGCCGTCAGCGACGCGGAGATGCTGCGCGCCGCGAAGGCCGAGCTGCGCAACTCGCGGCTGGGTGTGCTCTCCATCCCCGGCTTCGCCAGCGTCGAACGTGACCTCAAGCCCGCCCTCGACTGCGGCGTCGACGAGGTCCGGGTGGGCGCGCACTGCACCGAGGCCGACGTCACCCGCCAGCAAATCACGATGCTGCGGTCGATGGGCGTACGCGTGAAGGGCCTGCTGCTGATGAGCCACATGGCGTCGGCCGGGAAGCTGGTCGAGCAGGCGGGGCTCATGCAGGAGTACGGCGCCGAGGCGGTCGTGCTGATGGACTCGGCCGGCGCGTACACCCCGGAGATGGTCCGGGAAAAGGTCGGCGAGCTGGTCGAGAAGCTCGACATCGCGATCGGTTTCCACGCGCACAACAACCTGGGTCTCTCGGTGATCAACAGCATCACCGCGGTCCGCGCGGGTGCATCTATCGTGGACGTGACGGCACGTGGATTCGGCGCCGGGGCGGGGAACGCGCCGATCGAACTGGTCGCCGCCAACCTGCACGTCGAGCAGATCGAGGCGCGGATCAAGCTGTTCGACGCGCTGGACGCGGCGGACACCGCGGAGGAACGGTTCGTGAAACACGTGCCGACCAACGACGGCGTCACCATCGCCAGCGGCATCGCCGGGGTCTTCTCCGGGTTCGCGGCGCCGGTGCGGCGTGCCAGCCGGCGCTTCGGCGTCGACCCCCGCGAGATCCTGCTCGAGTTGGGCAGGCGGCGGGTGGTGGCCGGCCAGGAGGACACCATCATCGAGGTCGCCATGGCCCTGGCCGCCGAGGCGGCGTCCGCGGACCTGACGCACGCCTTTGTTGACCACATCTGA	MSVKLQICDSTLRDGNHAVAHQLGRADISAYARAAEEAGVDVLEVGHGNGLGASSIQVGIAAVSDAEMLRAAKAELRNSRLGVLSIPGFASVERDLKPALDCGVDEVRVGAHCTEADVTRQQITMLRSMGVRVKGLLLMSHMASAGKLVEQAGLMQEYGAEAVVLMDSAGAYTPEMVREKVGELVEKLDIAIGFHAHNNLGLSVINSITAVRAGASIVDVTARGFGAGAGNAPIELVAANLHVEQIEARIKLFDALDAADTAEERFVKHVPTNDGVTIASGIAGVFSGFAAPVRRASRRFGVDPREILLELGRRRVVAGQEDTIIEVAMALAAEAASADLTHAFVDHI	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	83.86	gnl|BL_ORD_ID|1253|hsp_num:0	1367			639	762	erythromycin; tylosin
BGC0000333.1|Cyclomarin_23 # 45703 # 46686 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.713	BGC0000333.1|Cyclomarin_23 	45703	46686	+	Loose	400	27.335	ErmB	19.32	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGAACGGAAAGACCCGGAAGTCGTGGCCGATGTGGCCGCAGTCGCCGCGCTGCTGCAGATCGGCGCCGAGATCGGAGCCGATCAGGTTCTGGACGCGGCCGAGCCGTTCAGCGCCGCGGACGTGGCCAAGGCAGTTGACGTCCCGGTCGCCGGCATCACCGCGTACCTGGGGGCGCTGCTCGCCGCAGGCCTGATCGCCGAGACCGAGGTTCCGGGCACCTACCAGGTGGCCGCCGACTACCCCGACCTGCGTTACCAGGCCGGGTACATGTGCTGGGCGATGAACGCGAACGGCCCCTTCCTGGACAACGCCCGCGCGTTCCTCACGGATCCGGCCGCGGCCGCCCAGGTCCACCGGCGCAACGGGCGGCGGGTCGCGATCAGCTCGCGGTGGATCGGCGAGCGCGCGTTCTACCCGCAGCTCATCGAGCAGGTTGTGGCAGCCGGGGCGCTGCGGGTGTCGGACCTCGGCGCCGGCGCCGGCGGGCTGCTCATCAAGCTGCTGCAGGAGGACCCGGCCCGTACCGGTACGGCGGTCGACAGCAACGGCGCGGCCTGTGCTGCGGCGCGGCAGGCCGCCCTCGCCGGCGGGGTGCACGATCGGCTGACGGTCGTCGAGCGGCCGATCGAGTCGCTGGTCGATGACCCCGAACCGGTCGCGGGCGCCGATGCCATTCTCGCCAGCTATGTCATGCACGACATCGTGGCCGACGACCGTATCGCCCTGGGTGTCCTGGGCGCCCTGCGCGACGCGCTGGCCCCAGGCGGATTTCTCGCCGTGGCCGACGCGGTCTCCTACGCGCGGCGACCGGAGGAGCGCACGTTCAGCGCCCTCTTCACCTACCTGCACGCCACCTTCATGAGCGTCACCCTCCCCGCCGAGCAGGAATGGCTGGACAAGTTCGCGGCGGCCGGCTTCTCGCAAACCAAGGTCGTTCCGATCGGCCTGCCCGGCGGTCGGCTCTTCGTGGCGACCAGATGA	MERKDPEVVADVAAVAALLQIGAEIGADQVLDAAEPFSAADVAKAVDVPVAGITAYLGALLAAGLIAETEVPGTYQVAADYPDLRYQAGYMCWAMNANGPFLDNARAFLTDPAAAAQVHRRNGRRVAISSRWIGERAFYPQLIEQVVAAGALRVSDLGAGAGGLLIKLLQEDPARTGTAVDSNGAACAAARQAALAGGVHDRLTVVERPIESLVDDPEPVAGADAILASYVMHDIVADDRIALGVLGALRDALAPGGFLAVADAVSYARRPEERTFSALFTYLHATFMSVTLPAEQEWLDKFAAAGFSQTKVVPIGLPGGRLFVATR	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	131.85	gnl|BL_ORD_ID|1424|hsp_num:0	1549			3	252	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000333.1|Cyclomarin_24 # 46683 # 47477 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0000333.1|Cyclomarin_24 	46683	47477	+	Loose	250	25.409	AAC(6')-29a	29.79	3002583	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACGGCCGTCGCGCGGACGTTGCACCGCGAACTTGCCGTGGAGCTCTGGGAGGCCGCCCGGACCCGTCGGCCGGTCCCGCCGCTGTCGGTCCGGCACCCGCGACTCGACCTGGCGGACGCGTACGCGATCCAGAGCGAGATCCGGGCGCTCGAACTGGCCGGTGGTGCCCGGCTCGCCGGCCTGAAGATCGGCGCCACCAGCGAGGCAATCCAGAAGATGTTCGGCATCGATCATCCTGACTTCGGCTATCTGACCGATCGCATGCTGCTGCCCGACGGCGTCGCTCTGGACGTGCGTACGTTCATCGCACCGAAGGTCGAGGGCGAGATCGCCTTCCGGATGGCCCGGGATCTGAGCGGCCCGGCGGTCACGGCCCAGGACGTTCTCGCGGCCACCACCGAGATCTGCCCGGTCCTGGAGGTCCTCGACAGCCGGATCGAGGCTTGGAAGATCGGCCTGGTGGACACCGTCGCCGACAACGCGTCTTCCGCAGCGGTCGTGGTCGGCGCCGGCGTCCCGCCGGACACGACCGACCTCGCGGCGGCGCGGATGGTGCTGCGCAGCGGTGACGCCGAATACACCGGGACCGGCTCGGCCGTCATGGGGCATCCCGCCGAGTCGGTGGCGTGCCTGGTCCGGATCCTGGCGGAGTTCGGCACCGGGGTCAGCGCCGGCAAGCTCGTGCTGGCCGGCTCCTGGGCCGGCGCGGTGGATCTGGTGCCGGGGGAACAGGTTCACGCCTCATTCGGCGTTCTGGGATCGGTCTCCATGACCTACGGATCAGAAGGTTAG	MTAVARTLHRELAVELWEAARTRRPVPPLSVRHPRLDLADAYAIQSEIRALELAGGARLAGLKIGATSEAIQKMFGIDHPDFGYLTDRMLLPDGVALDVRTFIAPKVEGEIAFRMARDLSGPAVTAQDVLAATTEICPVLEVLDSRIEAWKIGLVDTVADNASSAAVVVGAGVPPDTTDLAAARMVLRSGDAEYTGTGSAVMGHPAESVACLVRILAEFGTGVSAGKLVLAGSWAGAVDLVPGEQVHASFGVLGSVSMTYGSEG	MSVSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEGLVEVLIARDATGAAVGHVELSIRHDLEELQGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRVITHRKFAGSAV	198.50	gnl|BL_ORD_ID|269|hsp_num:0	300			33	174	dibekacin; amikacin; kanamycin A; tobramycin; isepamicin
